selected scholarly activity
-
books
-
chapters
- Chapter 154 Hematologic Manifestations of Renal Disease. 2244-2246. 2018
- Hematologic Manifestations of Renal Disease. 2244-2246. 2018
- Antiphospholipid Syndrome. 269-281. 2017
- The Direct Oral Anticoagulants. 253-268. 2017
- 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report. 317-338. 2017
- Hematologic Manifestations of Renal Disease. 2244-2246. 2017
- Prevention and Treatment of Thrombotic Antiphospholipid Syndrome. 223-233. 2017
- Perioperative Management of the Patient with Immune Thrombocytopenic Purpura De Novo and the Thrombocytopenia of Antiphospholipid Antibody Syndrome. 129-135. 2013
- Thrombosis. 67-77. 2013
- Direct Thrombin Inhibitors. 327-340. 2009
- Management of Antiphospholipid Antibody Syndrome. 168-175. 2008
- Antiphospholipid antibody syndrome. 49-66. 2001
-
conferences
- PREDICTORS OF ANEMIA RECOVERY IN PATIENTS WITH PRE-EXISTING ANEMIA UNDERGOING BARIATRIC-METABOLIC SURGERY. Obesity Surgery. 818-818. 2023
- Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Blood. 11045-11046. 2022
- Abstract P3: Andexanet Alfa for Acute Bleeding During Treatment With Edoxaban. Stroke. 2021
- Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors. Blood. 711-711. 2019
- Evaluating the Quality of Systematic Reviews & Meta-Analyses Published on Direct Oral Anticoagulants in the Past 5 Years. Blood. 5802-5802. 2019
- Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial. Blood. 3685-3685. 2019
- 579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis. American Journal of Gastroenterology. S332-S333. 2019
- Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study. European Heart Journal. 94-94. 2019
- The FIBRES Randomized Controlled Noninferiority Trial of Fibrinogen Concentrates Versus Cryoprecipitate in Cardiac Surgery: Subgroup and Safety Analysis. Transfusion. 8A-8A. 2019
- Andexanet alfa for treatment of factor Xa inhibitor-related acute major bleeding. Journal of Thrombosis and Thrombolysis. 608-608. 2019
- ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY. Critical Care Medicine. 2019
- VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING. Critical Care Medicine. 2019
- Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis. Blood. 2518-2518. 2018
- Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies. Transfusion. 2841-2860. 2018
- Recurrent Thrombosis in Patients with Antiphospholipid Antibodies Following an Initial Venous or Arterial Thromboembolic Event. Arthritis & Rheumatology. 2018
- USING AUTOMATIC CELL COUNTS TO CALCULATE THE I: T RATIO FOR INVESTIGATION OF EARLY ONSET NEONATAL SEPSIS. International Journal of Laboratory Hematology. 50-50. 2018
- Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI). European Heart Journal. 1050-1050. 2018
- RESUMPTION OF ANTICOAGULANT THERAPY AFTER ANTICOAGULANT-RELATED GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S220-S220. 2018
- Incidence of venous thromboembolic complications in controlled trials of inflammatory bowel disease. Journal of Crohn's and Colitis. S483-S484. 2018
- 202: ANDEXANET ALFA REVERSES ANTICOAGULATION INDUCED BY BETRIXABAN IN HEALTHY VOLUNTEERS. Critical Care Medicine. 83-83. 2018
- 33: PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF ANDEXANET ALFA DOSE IN ACUTE MAJOR BLEEDING. Critical Care Medicine. 17-17. 2018
- Using Automatic Cell Counts to Calculate the I:T Ratio for Investigation of Early Onset Neonatal Sepsis. Blood. 2017
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- Determining the Factors for Reassessment after Transfusion: A Canadian Survey. Transfusion. 170A-170A. 2017
- MODIFICATION AND VALIDATION OF A BARCODED CLAUSS FIBRINOGEN ASSAY FOR USE IN CORE LABORATORIES. International Journal of Laboratory Hematology. 77-77. 2017
- Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059). Neurology. 2017
- An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients. Blood. 2017
- Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome. Arthritis & Rheumatology. 2017
- THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome. Annals of the Rheumatic Diseases. 2017
- The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis. Journal of Thrombosis and Haemostasis. 2017
- Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers By Andexanet Alfa. Blood. 143-143. 2016
- Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study. Blood. 90-90. 2016
- Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis. Blood. 3821-3821. 2016
- ANDEXANET ALFA, A UNIVERSAL ANTIDOTE FOR REVERSAL OF ANTICOAGULATION OF FACTOR XA INHIBITORS IN HEALTHY HUMAN VOLUNTEERS. American Journal of Hematology. E382-E382. 2016
- Developing a Data-driven Research Program: An Integrated Database Network Tool Driving Education and Research Forward. Transfusion. 237A-237A. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- Assessment of low molecular weight heparin accumulation in patients with chronic kidney disease: results from the TRIVET study. Journal of Thrombosis and Haemostasis. 19-19. 2016
- Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment: Pharmacoeconomic Analysis of a Prospective Randomized Trial. Value in Health. A154-A155. 2016
- HOW DO THEY PERFORM? VALIDATION AND ASSESSMENT OF PERFORMANCE OF 19 COAGULATION ANALYZERS ACROSS A REGIONAL LABORATORY PROGRAM.. International Journal of Laboratory Hematology. 73-74. 2016
- Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.. Stroke. 2016
- ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors. Circulation. 2274-2274. 2015
- A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes. Blood. 4446-4446. 2015
- Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review. Blood. 5252-5252. 2015
- Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis. Blood. 1120-1120. 2015
- Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery. Blood. 1130-1130. 2015
- Non-Specific Hemostatic Agents (PCC, aPCC, rVIIa) for Reversal of Direct Oral Anticoagulant Effect in Patients with Major Bleeding Complications: A Retrospective Review. Blood. 1137-1137. 2015
- Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors. Blood. 428-428. 2015
- Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study. Blood. 3468-3468. 2015
- Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis. Blood. 430-430. 2015
- Systematic Review of Therapeutic Plasma Exchange for the Treatment of Catastrophic Antiphospholipid Antibody Syndrome. Journal of Rheumatology. 1269-1269. 2015
- A Canadian consensus on venous thromboembolism (VTE) prophylaxis prevention in thoracic surgery, a national Delphi consensus survey. Journal of Thrombosis and Haemostasis. 486-487. 2015
- ANNEXA (TM)-A PART 2: A phase 3 randomized, double-blind, placebo-controlled trial demonstrating sustained reversal of apixaban-induced anticoagulation in older subjects by andexanet ALFA (PRT064445), a universal antidote for factor XA (FXA) inhibitors. Journal of Thrombosis and Haemostasis. 84-85. 2015
- Feasibility of comparing intermittent pneumatic compression vs. a novel device for prevention of venous thromboembolism in trauma patients with contraindication to anticoagulation. Journal of Thrombosis and Haemostasis. 726-726. 2015
- Hemodialysis for the treatment of dabigatran-associated bleeding: a systematic review of the literature. Journal of Thrombosis and Haemostasis. 119-119. 2015
- Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review. Journal of Thrombosis and Haemostasis. 974-975. 2015
- OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS. Haematologica. 20-20. 2015
- Serum coagulation markers and cerebral MRI in lupus patients with antiphospholipid antibodies and cognitive dysfunction. Clinical and Experimental Rheumatology. S68-S68. 2015
- FATAL BLEEDING, CASE-FATALITY RATE OF MAJOR BLEEDING AND ALL-CAUSE MORTALITY IN PATIENTS TAKING TARGET-SPECIFIC ORAL ANTICOAGULANT, A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal of the American College of Cardiology. A2052-A2052. 2015
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal of Edoxaban-Induced Anticoagulation in Healthy Subjects By Andexanet Alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors. Blood. 4269-4269. 2014
- Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study. Blood. 3521-3521. 2014
- Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial. Blood. 2872-2872. 2014
- Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing. Blood. 4035-4035. 2014
- ANNEXA (TM)-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, Demonstrating Reversal of Apixaban-Induced Anticoagulation in Older Subjects by Andexanet alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors. Circulation. 2116-2117. 2014
- REVERSAL OF FACTOR XA INHIBITORS-INDUCED ANTICOAGULATION IN HEALTHY SUBJECTS BY ANDEXANET ALFA. Critical Care Medicine. 2014
- Sustained reversal of apixaban anticoagulation with andexanet alfa using a bolus plus infusion regimen in a phase 2 placebo controlled trial. European Heart Journal. 137-137. 2014
- Reversal of enoxaparin-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), an antidote for direct and indirect fXa inhibitors-a phase 2 randomized, double-blind, placebo-controlled trial. Journal of Thrombosis and Haemostasis. 7-7. 2014
- THE IMPACT OF BLEEDING COMPLICATIONS IN PATIENTS RECEIVING NOVEL ORAL ANTICOAGULANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Haematologica. 233-233. 2014
- Is an aspirate for morphology and flow cytometry really necessary when a trephine is also being performed in the diagnosis and staging of lymphoma?. British Journal of Haematology. 63-63. 2014
- Monitoring Of Medical And Surgical Patients In Mulago Hospital, Uganda: A Pilot Observational Study Using The Modified Early Warning Score. American Journal of Respiratory and Critical Care Medicine. 2014
- Risk of thromboembolism, recurrent bleeding and death after warfarin interruption for gastrointestinal bleeding. Journal of Thrombosis and Haemostasis. 10-10. 2013
- A Review Of Computed Tomography Pulmonary Angiograms In Three Teaching Hospitals: The Rise Of Sub-Segmental Pulmonary Emboli and Their Management. Blood. 932-932. 2013
- Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting. Blood. 1143-1143. 2013
- Evaluation Of The Appropriateness Of Frozen Plasma Usage In The Era Of Prothrombin Complex Concentrates: A Retrospective Study. Blood. 3664-3664. 2013
- Long Term Treatment and Prevention Of Recurrent VTE In Cancer Patients: Results Of The Canadian Proact Survey. Blood. 5581-5581. 2013
- Non-Invasive Hemoglobin Measurements In Anemic Patients. Blood. 2970-2970. 2013
- Rituximab For The Treatment Of Hepatitis C Associated IgM Mediated Cold Hemolytic Anemia – Case Report and Literature Review. Blood. 4653-4653. 2013
- Systematic Review and Meta-Analysis Of Rituximab For The Treatment Of Immune Thrombocytopenia In Adults. Blood. 1681-1681. 2013
- A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors. Journal of Thrombosis and Haemostasis. 30-30. 2013
- A review of computed tomography pulmonary angiograms in three teaching hospitals: the rise of sub-segmental pulmonary emboli and their management. Journal of Thrombosis and Haemostasis. 601-601. 2013
- Active site-mutated thrombin S195A but not active site-blocked thrombin counteracts the anticoagulant activity of dabigatran in plasma. Journal of Thrombosis and Haemostasis. 166-166. 2013
- Efficacy and safety of weight-adjusted extended duration tinzaparin for prevention of post-operative venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 821-821. 2013
- Prothrombin complex concentrate use for the emergency reversal of vitamin K antagonists. Journal of Thrombosis and Haemostasis. 819-819. 2013
- A Review of Computed Tomography Pulmonary Angiograms in Three Teaching Hospitals: the rise of Sub-Segmental Pulmonary Emboli. Journal of Thrombosis and Thrombolysis. 402-403. 2013
- Reversal of oral direct thrombin and factor Xa inhibitors: a systematic review. Journal of Thrombosis and Thrombolysis. 413-413. 2013
- MAJOR BLEEDING IN MEDICAL-SURGICAL CRITICALLY ILL PATIENTS IS ASSOCIATED WITH INCREASED USE OF BLOOD PRODUCTS, LONGER HOSPITAL STAY AND HIGHER MORTALITY. Critical Care Medicine. U39-U40. 2012
- THROMBOCYTOPENIA IN THE CRITICALLY ILL: INCIDENCE, RISK FACTORS AND IMPACT ON TRANSFUSIONS, BLEEDING, MORTALITY. Critical Care Medicine. U97-U97. 2012
- C0129 Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature. Thrombosis Research. S111-S111. 2012
- Prothrombin Complex Concentrates Reduce Blood Loss in Mice Rendered Coagulopathic by Warfarin but Not Dabigatran Etexilate. Transfusion. 56A-57A. 2012
- Bleeding Risk in Randomized Controlled Trials Comparing Warfarin and Aspirin: A Systematic Review and Meta-Analysis. American Journal of Hematology. S157-S157. 2012
- Death and Thrombosis After Interrupting Warfarin for Gastrointestinal Hemorrhage. American Journal of Hematology. S151-S152. 2012
- Heparin-Induced Thrombocytopenia In The ICU: ELISA Versus SRA Testing. A47. DIAGNOSTIC TECHNIQUES AND MONITORING. a1669-a1669. 2012
- Patterns Of Use, Efficacy, And Safety Of Recombinant Factor VIIa At An Academic Teaching Centre. B49. NON-PULMONARY CRITICAL CARE. a3163-a3163. 2012
- Published Prediction Models Do Not Discriminate Among Critically Ill Patients In Clinically Suspected Pulmonary Embolism In ICU. A106. ADVANCES IN DIAGNOSIS AND TREATMENT OF PULMONARY EMBOLISM. a2360-a2360. 2012
- Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Available Literature. American Journal of Hematology. S186-S187. 2012
- Use of Thrombolytic Agents for Pulmonary Embolism During Cardiopulmonary Resuscitation: Systematic Review and Teleoanalysis. American Journal of Hematology. S189-S190. 2012
- The pathogenesis of warfarin-associated venous limb ischemia and gangrene complicating cancer: clinical and laboratory parallels with heparin-induced thrombocytopenia (HIT). Thrombosis Research. S159-S160. 2012
- Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study. Blood. 554-555. 2011
- Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study. Blood. 997-997. 2011
- Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study. Blood. 1431-1432. 2011
- Laboratory HIT Testing in Critically III Patients. Blood. 93-93. 2011
- Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study. Blood. 324-324. 2011
- Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Literature. Blood. 1432-1432. 2011
- The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism. Blood. 1799-1799. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- A randomized controlled trial comparing aspirin with dalteparin for the prevention of venous thromboembolism following total hip arthroplasty. Journal of Thrombosis and Haemostasis. 303-303. 2011
- Does ABO blood group increase the rate of recurrent events after initial treatment for a first unprovoked venous thromboembolism (VTE) event? Reverse cohort subgroup analysis. Journal of Thrombosis and Haemostasis. 710-711. 2011
- Extended follow-up of the multi-center prospective cohort that derived the 'men continue and HERDOO2' clinical decision rule identifying low risk unprovoked patients. Journal of Thrombosis and Haemostasis. 39-40. 2011
- Amyloidosis and GCA/PMR: Case Report of a Rare Association. Journal of Rheumatology. 1176-1176. 2011
- Construction and validation of a clinical scoring model for heparin-induced thrombocytopenia (HIT). Haemophilia. 558-559. 2011
- Diagnostic And Outcome Prediction Models For Pulmonary Embolism In Critically Ill Patients: A Pilot Study. C50. CARDIOPULMONARY INTERACTIONS. a4743-a4743. 2011
- Methods Center Adjudication Costs For 5 Morbidity Outcomes In A Thromboprophylaxis Trial. American Journal of Respiratory and Critical Care Medicine. 2011
- PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Value in Health. A75-A75. 2011
- Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure. Journal of Thrombosis and Thrombolysis. 249-258. 2011
- Prothrombin Complex Concentrate (Octaplex (R)) In Patients Requiring Immediate Reversal of Vitamin K Antagonist Anticoagulation. Blood. 486-486. 2010
- SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature. Blood. 485-485. 2010
- Central Statistical Monitoring Of An International Thromboprophylaxis Trial. American Journal of Respiratory and Critical Care Medicine. 2010
- Neither Red Blood Cell Transfusion Nor Age Of Blood Predict Deep Vein Thrombosis In Medical-Surgical Critically Ill Patients. C44. CARDIOPULMONARY INTERACTIONS AND NON-PULMONARY CRITICAL CARE. a4556-a4556. 2010
- Weight loss is still a problem with reduced intensity conditioning transplants and modern supportive care. British Journal of Haematology. 70-70. 2010
- A Cohort Study of Warfarin Administered to Achieve An INR of 2.0 to 3.0 for the Prevention of Recurrent Venous Thrombosis in Patients with An Antiphospholipid Antibody. Blood. 1214-1214. 2009
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 575-575. 2009
- Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the "Men Continue and HERDOO2" Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).. Blood. 187-188. 2009
- Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically III Patients. Blood. 1535-1535. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin-in Patients with Immune Thrombocytopenic Purpura. Blood. 955-955. 2009
- Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors. Blood. 1162-1162. 2009
- Alignment to prophylaxis guidelines and occurrence of venous thromboembolism after total hip and knee replacement. Journal of Thrombosis and Haemostasis. 121-122. 2009
- Burden of illness of venous thromboembolism after total hip and knee replacement in Canada. Journal of Thrombosis and Haemostasis. 171-171. 2009
- CHOP DELETION DOES NOT MITIGATE THE PHENOTYPE OF THE P0 R98C MOUSE MODEL OF EARLY-ONSET CMT 1 B. Journal of the Peripheral Nervous System. 133-133. 2009
- Evaluating the feasibility of less frequent INR testing during chronic anticoagulation therapy. Journal of Thrombosis and Haemostasis. 474-475. 2009
- Hemorrhage in acute care setting is a risk factor for later venous thromboembolism in rehabilitation unit. Journal of Thrombosis and Haemostasis. 421-422. 2009
- Incidence and predictors of serious bleeding following polypectomy in patients receiving and not receiving oral anticoagulation therapy. Journal of Thrombosis and Haemostasis. 475-475. 2009
- JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism. a meta-analysis. Journal of Thrombosis and Haemostasis. 422-423. 2009
- Low-intensity adjusted-dose warfarin for the prevention of mechanical malfunction of doublelumen haemodialysis catheters: a randomized controlled trial. Journal of Thrombosis and Haemostasis. 268-268. 2009
- Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents. Journal of Thrombosis and Haemostasis. 107-110. 2009
- Natural history of mesenteric venous thrombosis in patients treated with oral anticoagulants. Journal of Thrombosis and Haemostasis. 422-422. 2009
- Validation of a diagnostic approach to exclude recurrent venous thromboembolism. Journal of Thrombosis and Haemostasis. 166-166. 2009
- Myelin Structural Integrity in a Model for Human Early-Onset CMT1B. Biophysical Journal. 461a-461a. 2009
- O8 Predicting DVT in pregnancy: out in “left” field?. Thrombosis Research. S133-S133. 2009
- Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients. Blood. 70-70. 2008
- Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study. Blood. 1041-1041. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review. Blood. 1170-1170. 2008
- The Impact of Deep Vein Thrombosis on Outcomes in Critically III Patients: A Systematic Review and Meta-Analysis. Blood. 1040-1040. 2008
- THE IMPACT OF DEEP VEIN THROMBOSISON ON OUTCOMES IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Haematologica. S117-S117. 2008
- THE IMPACT OF DEEP VEIN THROMBOSISON ON OUTCOMES IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Haematologica. S117-S117. 2008
- Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study. Pharmacotherapy. 960-967. 2008
- Nurse practioners improve compliance with venous thromboembolism prophylaxis in hospitalized heart failure patients at St. Joseph's Regional Medical Center. Circulation. E444-E445. 2008
- Differential effects of systems that generate reactive oxygen species on PNS myelin. Journal of Neurochemistry. 36-36. 2008
- Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. Journal of Thrombosis and Thrombolysis. 96-96. 2008
- The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS). Journal of Thrombosis and Thrombolysis. 127-128. 2008
- Attributable morbidity and mortality of DVT. Critical Care Medicine. A174-A174. 2007
- Increased detection of myocardial infarction in critical illness using screening troponin and eggs. Critical Care Medicine. A76-A76. 2007
- A negative D-dimer excludes recurrent deep vein thrombosis: Results of a multicentre management study.. Blood. 215A-215A. 2007
- Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.. Blood. 304-304. 2007
- Fibrinolytic Agents for Restoration of Central Venous Catheter Patency: A Systematic Review.. Blood. 971-971. 2007
- Evaluation of the CapillaryS 2 capillary electrophoresis system for hemoglobinopathy screening. International Journal of Laboratory Hematology. 9-9. 2007
- Acute HIT should be considered when cardio-respiratory arrest follows line insertion and/or heparin administration. Scottish Medical Journal. 47-48. 2007
- PO-44 Incidence of venous thromboembolism in patients undergoing thoracotomy for cancer. Thrombosis Research. S158-S159. 2007
- FRESH FROZEN PLASMA TRANSFUSION IN THE CRITICALLY ILL.. Critical Care Medicine. A10-A10. 2006
- A Multicentre Trial of the Effectiveness of ζ Globin Enzyme Linked Immunosorbent Assay (ELISA) and Hb H Inclusion Body Screening for the Detection of α Thalassemia Trait.. Blood. 1597-1597. 2006
- Evaluation of the CapillaryS 2 CE System for Hemoglobinopathy Investigations.. Blood. 3781-3781. 2006
- Safety and efficacy of anti-fibrinolytics in orthopedic surgery: A meta analysis of randomized trials.. Blood. 190A-190A. 2006
- The management of anticoagulated patients requiring dental extraction: A cross-sectional survey of oral surgeons and hematologists.. Blood. 190A-190A. 2006
- Transmission of Chromosomally Integrated HHV6 by Allogeneic Peripheral Blood Stem Cell Transplantation Associated with the Development of a Fatal Macrophage Activation (Haemophagocytic) Syndrome.. Blood. 5278-5278. 2006
- Unexpected harmful side effects triggered by immune modulation.. Blood. 80B-80B. 2006
- Use of therapeutic dose low molecular weight heparin in patients with renal insufficiency: Analysis of anti-Xa levels and creatinine clearance.. Blood. 265A-265A. 2006
- Postpartum management of women at increased risk of thrombosis results of a Canadian pilot survey.. Arthritis and Rheumatism. S558-S559. 2006
- Results from the HepASA trial: Low molecular weight heparin plus ASA vs ASA only for recurrent pregnancy loss.. Arthritis and Rheumatism. S558-S558. 2006
- New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management. Seminars in Hematology. S77-S83. 2006
- A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.. Blood. 173A-173A. 2005
- Anti-Xa levels and renal function: Analysis of the first 32 patients in the tinzaparin in renal insufficiency for venous thromboembolism study. Blood. 266A-266A. 2005
- Low molecular weight heparin and bleeding in patients with severe renal failure: A meta-analysis. Blood. 266A-266A. 2005
- Rituximab for the treatment of adults with ITP: A systematic review. Blood. 361A-361A. 2005
- Trends in AIDS-Associated Cancers among Patients Attending a Palliative Care Service in Uganda in the ’Pre-HAART’ Era, 1994–2002.. Blood. 4654-4654. 2005
- Use of low dose oral vitamin K in the treatment of patients with INR values of more than 10.0.. Blood. 163A-163A. 2005
- I. Grades of recommendations and the levels of evidence. Journal des Maladies Vasculaires. 2005
- A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.. Blood. 143A-143A. 2004
- Anti-Xa levels in critically ill patients receiving dalteparin for thromboprophylaxis.. Blood. 105B-105B. 2004
- Comparison of compression ultrasound vs ascending contrast venography for proximal DVT in medical-surgical ICU patients.. Blood. 712A-713A. 2004
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.. Blood. 1784-1784. 2004
- Platelet Transfusions in a Medical- Surgical Intensive Care Unit.. Blood. 3637-3637. 2004
- Prevalence and Incidence of Arterial and Venous Thrombosis in Critically Ill Patients.. Blood. 2201-2201. 2004
- Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Disease: A Meta-Analysis of Randomized Trials.. Blood. 1778-1778. 2004
- Safety and efficacy of venous thromboembolism prophylaxis with low molecular weight heparin in hospitalised patients with acute medical illness and renal failure.. Blood. 106B-106B. 2004
- Significant Differences in Neutralization of Heparin and Its Low Molecular Fragments by Protamine Sulfate: An In Vivo Study.. Blood. 1850-1850. 2004
- The Safety of Co-Administered Low-Molecular-Weight Heparin and Continuous Epidural Analgesia after Major Orthopedic Surgery: Assessment of a Standardized Management Protocol.. Blood. 704-704. 2004
- The risk of hemorrhage and the frequency of vitamin K use in asymptomatic patients with warfarin-associated coagulopathy.. Blood. 153A-153A. 2004
- Screening results for 847 women attending a recurrent pregnancy loss clinic.. Arthritis and Rheumatism. S71-S72. 2004
- Are brand-name and generic warfarin interchangeable?. Clinical Pharmacology and Therapeutics. P27-P27. 2004
- Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome. Thrombosis Research. 443-446. 2004
- Optimal therapy of patients with antiphospholipid antibodies and thrombosis: The next steps. Thrombosis Research. 618-618. 2004
- Heparin-induced thrombocytopenia in medical-surgical ICU patients. Critical Care Medicine. A73-A73. 2003
- A paper-based warfarin algorithm for maintenance of anticoagulation within an INR range of 2.0 to 3.0. Blood. 324A-324A. 2003
- Periprocedural anticoagulation for patients with mechnical heart valves: A survey of 324 clinicians.. Blood. 753A-754A. 2003
- Periprocedural anticoagulation in patients with mechanical heart valves: An international survey of expert clinicians.. Blood. 324A-324A. 2003
- Prevalence and predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis: Results from a randomized trial comparing two intensities of anticoagulation.. Blood. 57A-57A. 2003
- Red blood cell transfusion practices in a teaching hospital intensive care unit - Has the TRICC trial changed our standard of care?. Blood. 557A-557A. 2003
- The percentage of hemoglobin Barts as a predictor for the alpha thalassemia genotype in cord blood samples.. Blood. 33B-33B. 2003
- Video laparoscopic surgery: Is the out-of-hospital thromboprophylaxis necessary?. Blood. 325A-326A. 2003
- Cardiac disease, vascular disease and medication use in patients with chronic renal insufficiency referred to nephrologists.. Journal of the American Society of Nephrology. 792A-792A. 2003
- Metabolic complications in patients with chronic renal insufficiency referred to nephrologists.. Journal of the American Society of Nephrology. 791A-791A. 2003
- Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy. Journal of Thrombosis and Thrombolysis. 69-72. 2003
- CALCULATED CREATININE CLEARANCE IN ICU PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN: AN INTER-RATER RELIABILITY STUDY. Critical Care Medicine. A154-A154. 2002
- DOPPLER COMPRESSION ULTRASOUND OF THE LOWER EXTREMITIES IN ICU PATIENTS: AN INTER-RATER RELIABILITY STUDY. Critical Care Medicine. A77-A77. 2002
- RELATIONSHIP BETWEEN TROUGH ANTI-XA LEVELS AND CALCULATED CREATININE CLEARANCE IN ICU PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN. Critical Care Medicine. A154-A154. 2002
- A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies.. Blood. 148A-148A. 2002
- An assessment of APTT heparin therapeutic reference intervals in Ontario. Blood. 97B-97B. 2002
- Case-fatality for major bleeding and intracranial hemorrhage in patients with venous thromboembolism on long-term oral anticoagulant therapy: A systematic review.. Blood. 705A-705A. 2002
- Diagnosis of deep vein thrombosis during pregnancy: A pilot study evaluating the role of D-dimer and compression leg ultrasound during pregnancy.. Blood. 275A-275A. 2002
- Low-intensity (INR 1.5-1.9) versus conventional-intensity (INR 2.0-3.0) anticoagulation for extended treatment of unprovoked VTE: A randomized double blind trial.. Blood. 150A-150A. 2002
- Variation of APTT EQA results obtained with various combinations of coagulation instruments and APTT reagents. Blood. 97B-97B. 2002
- Employing a validated assessment tool to evaluate interactions of warfarin with drugs and food.. Clinical Pharmacology and Therapeutics. P23-P23. 2002
- Twice daily enoxaparin, but not once daily dalteparin, is associated with elevated anti-factor Xa heparin levels at the time of epidural catheter removal.. Blood. 707A-707A. 2001
- Effectiveness of reconstituted and then frozen tPA for dysfunctional percutaneous dialysis catheters.. Blood. 92B-92B. 2000
- Factor V Leiden and arterial ischemic stroke in children: A meta-analysis.. Blood. 645A-+. 2000
- Sulfate density of the low molecular weight heparins determine their protamine neutralizability.. Blood. 649A-649A. 2000
- Treatment of excessive anticoagulation due to warfarin with oral vitamin K: A randomized controlled trial.. Blood. 450A-450A. 2000
- Use of vitamin K to reverse warfarin-induced excessive anticoagulation: A survey of current practice habits.. Blood. 104B-104B. 2000
- Incomplete neutralization of low molecular weight heparin by protamine is due to decreased binding affinity. Pediatric Research. 248A-248A. 2000
- Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients. Thrombosis Research. 133-138. 2000
- An interim analysis to improve precision of warfarin anticoagulation control in a randomized clinical trial.. Blood. 115B-115B. 1999
- Assessment of a xi-globin enzyme-linked immuno-sorbent assay (ELISA) for the detection of alpha-thalassemia trait.. Blood. 424A-424A. 1999
- In vitro assessment of hemostasis by the PFA-100 (TM): Direct comparison to bleeding in vivo in a rabbit ear bleeding model.. Blood. 23A-23A. 1999
- Stabilty and sterility of recombinant tissue plasminogen activator under-39 degrees C.. Blood. 24A-24A. 1999
- Incomplete neutralization of low molecular weight heparin by protamine results from decreased binding affinity. Thrombosis and Haemostasis. 451-452. 1999
- Abnormal fibrinolysis does not predispose to first or recurrent thromboembolism.. Blood. 355A-355A. 1998
- Effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.. Blood. 361A-361A. 1998
- Bone density results in women treated with low molecular weight heparin (LMWH) in pregnancy. Arthritis and Rheumatism. 637-637. 1997
- Low molecular weight heparin (LMWH) and ASA therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL).. Arthritis and Rheumatism. 1635-1635. 1997
- A randomized comparison of a 5 mg and 10 mg loading dose for the initiation of warfarin therapy. Thrombosis and Haemostasis. O2382-O2382. 1997
- Alternative method for detecting APC resistance (APCR) in patients receiving warfarin (W). Thrombosis and Haemostasis. PS79-PS79. 1997
- Comparison of 3 assays for the measurement of activated protein C resistance (APCR). Thrombosis and Haemostasis. PS78-PS78. 1997
- Comparison of 3 assays for the measurement of activated protein C resistance (APCR).. Clinical Chemistry. 670-670. 1997
- Diagnosis of a first dvt in outpatients: Interim analysis of a management based on clinical evaluation and D-dimer (SimpliRED(TM)) results. Thrombosis and Haemostasis. O2400-O2400. 1997
- Relationship of factor V Leiden genotype to risk of acute deep vein thrombosis following joint replacement surgery. Thrombosis and Haemostasis. S2351-S2351. 1997
- Low-dose oral vitamin K for the reversal of warfarin associated coagulopathy. Blood. 699-699. 1996
- Activated protein C resistance is not associated with postoperative deep vein thrombosis in patients undergoing hip or knee surgery.. Blood. 2450-2450. 1995
- Splenectomy reduces the frequency of relapse in patients with chronic relapsing TTP.. Blood. 343-343. 1995
- USE OF VARIOUS INDEXES IN POPULATION-BASED SCREENING FOR THALASSEMIA - UTILITY OF THE MEAN CORPUSCULAR VOLUME. Blood. A555-A555. 1994
-
journal articles
- Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation. Thrombosis Research. 237:88-93. 2024
- Anticoagulation for mechanical aortic valves: An international survey of current practice patterns and perceptions. Thrombosis Update. 14:100164-100164. 2024
- Primary prevention of venous thromboembolism for cancer patients in randomized controlled trials: a bibliographical analysis of funding and trial characteristics. Research and Practice in Thrombosis and Haemostasis. 8:102315-102315. 2024
- Efficacy of Vitamin C with Iron Supplementation in Iron Deficiency Anemia Patients: A Systematic Review and Meta-Analysis. Blood. 142:1091-1091. 2023
- Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review. Blood. 142:7200-7200. 2023
- Leukostasis Twist in Mantle Cell Lymphoma: Systematic Review and Case Report. Blood. 142:6132-6132. 2023
- Risk of Anemia and Vitamin B12 Deficiency in Patients with Type 2 Diabetes Mellitus on Metformin Therapy: A Systematic Review and Meta-Analysis. Blood. 142:5201-5201. 2023
- Safety and Efficacy of Direct Oral Anticoagulants in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis. Blood. 142:5534-5534. 2023
- Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care. Journal of the American Medical Association (JAMA). 330:1872-1872. 2023
- RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME. Canadian Journal of Diabetes. 47:S211-S211. 2023
- Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thrombosis Research. 231:32-38. 2023
- 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the Rheumatic Diseases. 82:1258-1270. 2023
- A new approach to antiphospholipid antibody syndrome. Research and Practice in Thrombosis and Haemostasis. 7:102226-102226. 2023
- OC 21.2 Safety of DOACs in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Research and Practice in Thrombosis and Haemostasis. 7:100661-100661. 2023
- OC 54.3 Direct Oral Anticoagulants vs Low Molecular Weight Heparin in the Management of Patients with Primary or Metastatic Brain Tumours: A Systematic Review and Meta-Analysis. Research and Practice in Thrombosis and Haemostasis. 7:100594-100594. 2023
- PB0485 Use of DOACs in the Management of Upper Extremity Deep Venous Thrombosis: A Systematic Review. Research and Practice in Thrombosis and Haemostasis. 7:101900-101900. 2023
- PB1478 Attributes of Randomized Controlled Trials and Their Associations with Funding Sources in Venous Thromboembolism Prophylaxis for Patients with Cancer: A Bibliographical Analysis. Research and Practice in Thrombosis and Haemostasis. 7:101863-101863. 2023
- RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME. Canadian Journal of Cardiology. 39:S253-S254. 2023
- Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis. 21:2963-2976. 2023
-
The 2023
ACR /EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & Rheumatology. 75:1687-1702. 2023 - Direct oral anticoagulants for the treatment of splanchnic vein thrombosis – A systematic review and meta-analysis. Thrombosis Research. 229:209-218. 2023
- Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial. Canadian Journal of Anaesthesia. 70:1008-1018. 2023
- Neutropénie. CANADIAN MEDICAL ASSOCIATION JOURNAL. 195:E598-E598. 2023
- Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors. Circulation. 147:1026-1038. 2023
- Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. Journal of Thoracic and Cardiovascular Surgery. 165:794-824.e6. 2023
- Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism. Research and Practice in Thrombosis and Haemostasis. 7:100068-100068. 2023
- Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of Thrombosis and Thrombolysis. 55:355-364. 2023
- Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing. Research and Practice in Thrombosis and Haemostasis. 7:100107-100107. 2023
- Warfarin Is the Preferred Therapy for Patients With Thrombotic APS. Journal of the American College of Cardiology. 81:31-33. 2023
- Neutropenia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 194:E1689-E1689. 2022
- Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. European Journal of Cardio-thoracic Surgery. 63:ezac488. 2022
- Restrictive versus liberal transfusion for anemic patients with acute myocardial infarction: Systematic review and meta-analysis. Health Sciences Review. 5:100059-100059. 2022
- A Historical Perspective on the Reversal of Anticoagulants. Seminars in Vascular Medicine. 48:955-970. 2022
- Efficacy and safety of pre-operative insertion of inferior vena cava filter in patients undergoing bariatric surgery: a systematic review. Journal of Thrombosis and Thrombolysis. 54:502-523. 2022
- Direct oral anticoagulants after bariatric surgery—What is the evidence?. Journal of Thrombosis and Haemostasis. 20:1988-2000. 2022
- Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial. British Journal of Anaesthesia. 129:294-307. 2022
- Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum. Journal of Thrombosis and Thrombolysis. 54:197-210. 2022
- Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review. European Journal of Haematology. 109:166-181. 2022
- Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels. Thrombosis Research. 215:1-4. 2022
- Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban. Thrombosis and Haemostasis. 122:998-1005. 2022
- Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?. Thrombosis and Haemostasis. 122:871-878. 2022
- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. New England Journal of Medicine. 386:1766-1768. 2022
- Canadian Conference on Medical Education 2022 abstracts. Canadian Medical Education Journal. 13:105-251. 2022
- Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review. Thrombosis Research. 213:16-26. 2022
- Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire. CANADIAN MEDICAL ASSOCIATION JOURNAL. 194:E565-E568. 2022
- Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves. Journal of Thrombosis and Thrombolysis. 53:697-707. 2022
- Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis. British Journal of Haematology. 197:e9-e11. 2022
- Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis. Critical Care Medicine. 50:e370-e381. 2022
- Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review. Research and Practice in Thrombosis and Haemostasis. 6:e12724-e12724. 2022
- Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial. Academic Emergency Medicine. 29:150-158. 2022
- VTE Prophylaxis in Critically Ill Adults. Chest. 161:418-428. 2022
- Management of intentional overdose of low-molecular-weight heparin. CANADIAN MEDICAL ASSOCIATION JOURNAL. 194:E122-E125. 2022
- Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Current Oncology. 28:5434-5451. 2021
- Equity and Game-Theory Strategies to Promote Gender Diversity and Inclusion in an Academic Health Science Centre. CJC OPEN. 3:S53-S61. 2021
- Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19. BMJ Evidence-Based Medicine. 26:302-306. 2021
- Iron Chelation Therapy in Low- to Intermediate- Risk Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis. Blood. 138:4661-4661. 2021
- Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review. Blood. 138:3221-3221. 2021
- Challenging anticoagulation cases: A case of heparin-induced-thrombocytopenia in the first trimester of pregnancy. Thrombosis Research. 207:58-61. 2021
- Evaluation of the sexual health in people living with hemophilia. Haemophilia. 27:993-1001. 2021
- A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations. Blood Advances. 5:3931-3936. 2021
- Detection of right ventricular dysfunction in acute pulmonary embolism by computed tomography or echocardiography: A systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 19:2504-2513. 2021
- Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis Care and Research. 73:1490-1501. 2021
- Iron supplementation following bariatric surgery: A systematic review of current strategies. Obesity Reviews. 22:e13268. 2021
- Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary. Journal of Thrombosis and Haemostasis. 19:2359-2360. 2021
- Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange. Platelets. 32:828-831. 2021
- Evaluating the quality of systematic reviews and meta-analyses published on direct oral anticoagulants in the past 5 years. BMJ Evidence-Based Medicine. 26:167-171. 2021
- Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients. Thrombosis and Haemostasis. 121:1097-1106. 2021
- Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis. TH Open. 05:e438-e448. 2021
- Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Stroke. 52:2096-2105. 2021
- Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study. Journal of Thrombosis and Haemostasis. 19:1526-1532. 2021
- ANDEXANET ALFA FOR ACUTE BLEEDING DURING TREATMENT WITH ENOXAPARIN. Journal of the American College of Cardiology. 77:1856-1856. 2021
- Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020. International Journal of Stroke. 16:321-341. 2021
- Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Critical Care Medicine. 49:e219-e234. 2021
- Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin. Research and Practice in Thrombosis and Haemostasis. 5:308-313. 2021
- Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CT. International Journal of Stroke. 16:192-199. 2021
- Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more. Thrombosis Research. 198:1-6. 2021
- Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. British Journal of Anaesthesia. 126:163-171. 2021
- Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer. Seminars in Thoracic and Cardiovascular Surgery. 33:1123-1134. 2021
- Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study. British Journal of Anaesthesia. 126:172-180. 2021
- Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Critical Reviews in Oncology/Hematology. 157:103125-103125. 2021
- A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot and Feasibility Studies. 6:52. 2020
- Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot and Feasibility Studies. 6:67. 2020
- Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide. BMC Medical Research Methodology. 20:113. 2020
- Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Advances. 4:5373-5377. 2020
- Detection of Right Ventricular Dysfunction in Acute Pulmonary Embolism By CT Scan: A Systematic Review and Meta-Analysis. Blood. 136:25-26. 2020
- Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study. Blood. 136:21-22. 2020
- Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts. Research and Practice in Thrombosis and Haemostasis. 4:1251-1261. 2020
- Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review. Thrombosis Research. 194:240-245. 2020
- Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. The Lancet Haematology. 7:e746-e755. 2020
- Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis. Journal of Vascular Surgery. 72:1506-1506. 2020
- Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 18:2308-2317. 2020
- Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery. 60:469-478. 2020
- Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 18:2274-2286. 2020
- Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 18:2126-2137. 2020
- Evaluating Trends in COVID-19 Research Activity in Early 2020: The Creation and Utilization of a Novel Open-Access Database. Cureus. 12:e9943. 2020
- Iron deficiency following bariatric surgery: a retrospective cohort study. Blood Advances. 4:3639-3647. 2020
- Investigation and management of erythrocytosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E913-E918. 2020
- First case of osteosarcoma in a dinosaur: a multimodal diagnosis. The Lancet Oncology. 21:1021-1022. 2020
- First case of osteosarcoma in a dinosaur: a multimodal diagnosis.. The Lancet Oncology. 21:1021-1022. 2020
- The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value. European Journal of Internal Medicine. 78:26-27. 2020
- A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin. International Journal of Hematology. 112:1-7. 2020
- Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry). Blood Advances. 4:2460-2467. 2020
- GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy. Journal of Clinical Epidemiology. 122:129-141. 2020
- GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. 122:142-152. 2020
- Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature. Lupus. 29:631-639. 2020
- Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10. Journal of Thrombosis and Haemostasis. 18:1133-1140. 2020
- Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Thrombosis and Haemostasis. 120:484-494. 2020
- A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers. Blood Advances. 4:728-739. 2020
- A practical approach to evaluating postoperative thrombocytopenia. Blood Advances. 4:776-783. 2020
- Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood. 135:239-251. 2020
- Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial. Thrombosis and Haemostasis. 120:132-140. 2020
- Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction. Hematology. 25:112-117. 2020
- Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. The Lancet Haematology. 7:e18-e27. 2020
- Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis. Thrombosis Research. 184:58-61. 2019
- Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thrombosis Research. 184:16-23. 2019
- Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery. Journal of the American Medical Association (JAMA). 322:1966-1966. 2019
- Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic. Blood. 134:4-4. 2019
- The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 17:1956-1965. 2019
- Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide 2019
- Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report. A and A Practice. 13:306-309. 2019
- 288Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study. European Heart Journal. 40. 2019
- Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 8:e012877. 2019
- North America anticoagulation forum guidance on reversal of direct oral anticoagulants. European Journal of Internal Medicine. 67:30-32. 2019
- The association between platelet dysfunction and adverse outcomes in cardiac surgical patients. Anaesthesia. 74:1130-1137. 2019
- Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events. American Journal of Tropical Medicine and Hygiene. 101:418-421. 2019
- Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum. American Journal of Hematology. 94:697-709. 2019
- Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy. Journal of the American Medical Association (JAMA). 321:1993-1993. 2019
- Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study. Haemophilia. 25:365-372. 2019
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. New England Journal of Medicine. 380:1326-1335. 2019
- Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis. Thrombosis Research. 175:102-109. 2019
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. European Journal of Epidemiology (EJE). 34:173-190. 2019
- Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review. Current Oncology. 26:106-110. 2019
- 496: VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING. Critical Care Medicine. 47:228-228. 2019
- 59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY. Critical Care Medicine. 47:30-30. 2019
- How can we reverse bleeding in patients on direct oral anticoagulants?. Kardiologia Polska. 77:3-11. 2019
- Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains. Haemophilia. 25:75-83. 2019
- Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials. Anesthesiology. 129:1092-1100. 2018
- Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thrombosis and Haemostasis. 118:2188-2188. 2018
- Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. Thrombosis Journal. 16:34. 2018
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances. 2:3257-3291. 2018
- Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia. Blood Advances. 2:3155-3162. 2018
- Andexanet alfa for the treatment of hemorrhage. Expert Review of Hematology. 11:847-855. 2018
- Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia. Annals of Hematology. 97:2055-2059. 2018
- Treatment Algorithm in Cancer-Associated Thrombosis: Canadian Expert Consensus. Current Oncology. 25:329-337. 2018
- Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 16:2008-2015. 2018
- Higher-risk APS: do we dare to DOAC?. Blood. 132:1357-1358. 2018
- Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. European Journal of Haematology. 101:362-367. 2018
- Soluble CD200 in secretory phase endometriosis endometrial venules may explain endometriosis pathophysiology and provide a novel treatment target. Journal of Reproductive Immunology. 129:59-67. 2018
- 5069Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI). European Heart Journal. 39. 2018
- Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. BMJ Open. 8:e021900-e021900. 2018
- Inferior Vena Cava Filter Placement With Catheter-Directed Lysis. JACC: Cardiovascular Interventions. 11:1398-1400. 2018
- Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 16:1288-1295. 2018
- 1109 - Resumption of Anticoagulant Therapy after Anticoagulantrelated Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. Gastroenterology. 154:S-220. 2018
- Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil. Journal of Thrombosis and Thrombolysis. 45:578-587. 2018
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thrombosis and Haemostasis. 118:842-851. 2018
- Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial. BMJ Open. 8:e020741-e020741. 2018
- Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. American Journal of Medicine. 131:430-437. 2018
- Resolving Concerns With the Newer Oral Anticoagulant Medications. Journal of the American College of Cardiology. 71:1114-1116. 2018
- Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. New England Journal of Medicine. 378:699-707. 2018
- Severe coagulopathy after a massasauga rattlesnake bite. CANADIAN MEDICAL ASSOCIATION JOURNAL. 190:E191-E194. 2018
- Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Thrombosis Research. 162:104-109. 2018
- The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding. American Journal of Hematology. 93:E42-E45. 2018
- Assessment of the Measurement Error in Cyclosporine Levels Drawn Between Peripheral and Central Sources. American Journal of Clinical Pathology. 149:76-81. 2018
- Dual and triple antithrombotic therapies: current patterns of practice and controversies. Kardiologia Polska. 76:937-944. 2018
- Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLoS ONE. 13:e0198285-e0198285. 2018
- McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 16:1656-1664. 2018
- Designing a successful capacity-building program in a low-income country: the St. Joseph’s Health System–McMaster–Makerere International Outreach Program Collaboration for Uganda. Blood Advances. 1:1-4. 2017
- The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis. Blood. 130:627-627. 2017
- Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor. Journal of Biological Chemistry. 292:21180-21192. 2017
- Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis. Thrombosis Research. 160:97-104. 2017
- Extended venous thromboembolism prophylaxis comparing rivaroxaban to aspirin following total hip and knee arthroplasty. Revue de Chirurgie Orthopedique et Traumatologique. 103:S124-S124. 2017
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode. Journal of Thrombosis and Haemostasis. 15:1977-1980. 2017
- Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa. Blood Advances. 1:1827-1838. 2017
- 314 Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa. Neurosurgery. 64:267-267. 2017
- Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study. CMAJ open. 5:E594-E603. 2017
- Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis. Blood. 15:1322-1333. 2017
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 1:103-111. 2017
- The direct oral anticoagulants: can we finally stop using rat poison?. Blood Advances. 1:980-980. 2017
- Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?. Annals of Hematology. 96:1033-1036. 2017
- Specific antidotes for bleeding associated with direct oral anticoagulants. The BMJ. 357:j2216-j2216. 2017
- Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta‐analysis. Vox Sanguinis. 112:268-278. 2017
- Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism. New England Journal of Medicine. 376:1279-1280. 2017
- Clinical evaluation of a hemochromatosis next‐generation sequencing gene panel. European Journal of Haematology. 98:228-234. 2017
- Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis. ClinicoEconomics and Outcomes Research. Volume 9:65-73. 2017
- Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants. Chest. 151:127-138. 2017
- Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature. Case Reports in Hematology. 2017:1-11. 2017
- Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours. Thrombosis and Haemostasis. 117:589-594. 2017
- Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey. Journal of Thoracic Disease. 9:80-87. 2017
- 2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1. Polskie Archiwum Medycyny Wewnetrznej. 126:1024-1024. 2016
- Andexanet Alfa for Factor Xa Inhibitor Reversal. New England Journal of Medicine. 375:2498-2500. 2016
- Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2. Polskie Archiwum Medycyny Wewnetrznej. 126:1025-1025. 2016
- VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3. Polskie Archiwum Medycyny Wewnetrznej. 126:1026-1027. 2016
- Reversal of direct oral anticoagulants: a practical approach. Hematology. American Society of Hematology. Education Program. 2016:612-619. 2016
- Thrombosis and anticoagulation in the setting of renal or liver disease. Hematology. American Society of Hematology. Education Program. 2016:188-195. 2016
- A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature. BMC Hematology. 16:17. 2016
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 14:2304-2307. 2016
- Point-of-Care Hemostatic Testing in Cardiac Surgery. Circulation. 134:1152-1162. 2016
- Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report. American Journal of Medicine. 129:e247-e248. 2016
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. New England Journal of Medicine. 375:1131-1141. 2016
- Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature. Seminars in Vascular Medicine. 42:671-681. 2016
- Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thrombosis and Haemostasis. 116:879-890. 2016
- The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis. Blood Coagulation and Fibrinolysis. 27:648-652. 2016
- 176 Andexanet Alfa. Neurosurgery. 63:170-170. 2016
- Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study. American Journal of Hematology. 91:E327-E329. 2016
- Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. European Journal of Epidemiology (EJE). 31:541-561. 2016
- Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study. Journal of Thrombosis and Haemostasis. 14:1206-1210. 2016
- Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?. Current Rheumatology Reports. 18:26. 2016
- Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of Thrombosis and Thrombolysis. 41:548-548. 2016
- Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem. Journal of Thoracic and Cardiovascular Surgery. 151:992-999. 2016
- Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation. CANADIAN MEDICAL ASSOCIATION JOURNAL. 188:361-362. 2016
- Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study. Journal of Thrombosis and Haemostasis. 14:504-509. 2016
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 14:623-627. 2016
- Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture. Journal of Bone and Joint Surgery. American volume. 98:316-316. 2016
- Abstract 212: Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers. Stroke. 47. 2016
- Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions. Journal of General Internal Medicine. 31:147-148. 2016
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection. Journal of the American Medical Association (JAMA). 315:142-142. 2016
- 2015 in hematology and thromboembolism. Polskie Archiwum Medycyny Wewnetrznej. 126:1024-1024. 2016
- Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information. Thrombosis and Haemostasis. 116:590-591. 2016
- Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of Thrombosis and Thrombolysis. 41:32-67. 2016
- Milestones in VTE treatment. Polskie Archiwum Medycyny Wewnetrznej. 126:1025-1025. 2016
- Modified Early Warning Score (MEWS) Identifies Critical Illness among Ward Patients in a Resource Restricted Setting in Kampala, Uganda: A Prospective Observational Study. PLoS ONE. 11:e0151408-e0151408. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. Thrombosis and Haemostasis. 116:480-485. 2016
- Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open. 6:e010569-e010569. 2016
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. New England Journal of Medicine. 373:2413-2424. 2015
- 101. Critical Care Medicine. 43:26-27. 2015
- Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example. Journal of Cancer Education. 30:754-758. 2015
- Systematic review of anticoagulant treatment of catheter-related thrombosis. Thrombosis Research. 136:1103-1109. 2015
- Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thrombosis and Haemostasis. 113:1193-1202. 2015
- Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials. Journal of Thrombosis and Haemostasis. 13:2012-2020. 2015
- Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Thrombosis Research. 136:1040-1044. 2015
- Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review. Journal of Thrombosis and Haemostasis. 13:1790-1798. 2015
- The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.. Blood Transfusion. 13:559-568. 2015
- Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine (United States). 94:e1479-e1479. 2015
- A 42-year-old man with elevated ferritin. CANADIAN MEDICAL ASSOCIATION JOURNAL. 187:820-821. 2015
- Antidotes for Novel Oral Anticoagulants. Arteriosclerosis, Thrombosis and Vascular Biology. 35:1736-1745. 2015
- Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome. Blood. 126:486-493. 2015
- A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures. Journal of Orthopaedic Trauma. 29:224-230. 2015
- Aspirin in secondary prevention of recurrent venous thromboembolism. Journal of Thrombosis and Thrombolysis. 39:392-394. 2015
- Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study. Vox Sanguinis. 108:274-280. 2015
- The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments. Annals of Hematology. 94:541-545. 2015
- ANNEXATM-R: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, DEMONSTRATING REVERSAL OF RIVAROXABAN-INDUCED ANTICOAGULATION IN OLDER SUBJECTS BY ANDEXANET ALFA (PRT064445), A UNIVERSAL ANTIDOTE FOR FACTOR XA (FXA) INHIBITORS. Journal of the American College of Cardiology. 65:A23-A23. 2015
- Clinical Challenges in Patients with Cancer-Associated Thrombosis: Canadian Expert Consensus Recommendations. Current Oncology. 22:49-59. 2015
- Failure of Anticoagulant Thromboprophylaxis. Critical Care Medicine. 43:401-410. 2015
- Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 2:e75-e81. 2015
- Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes. Journal of Thrombosis and Haemostasis. 13:214-218. 2015
- Venous Thromboembolism Prophylaxis in Critically Ill Patients. Seminars in Vascular Medicine. 41:068-074. 2015
-
d -Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. ACP journal club. 162:27-34. 2015 - Coronary Artery Calcification, Cardiovascular Events, and Death: A Prospective Cohort Study of Incident Patients on Hemodialysis. Canadian Journal of Kidney Health and Disease. 2:65-65. 2015
- Examining the Clinical Use of Hemochromatosis Genetic Testing. Canadian Journal of Gastroenterology and Hepatology. 29:41-45. 2015
- Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy. Annals of Pharmacotherapy. 49:125-126. 2015
- Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities. Blood. 125:195-198. 2015
- Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. Thrombosis and Haemostasis. 114:819-825. 2015
- Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. Blood. 124:2799-2799. 2014
- 455. Critical Care Medicine. 42:A1469-A1469. 2014
- The use of body condition and haematology to detect widespread threatening processes in sleepy lizards (Tiliqua rugosa) in two agricultural environments. Royal Society Open Science. 1:140257-140257. 2014
- Design of the rivaroxaban for heparin-induced thrombocytopenia study. Journal of Thrombosis and Thrombolysis. 38:485-492. 2014
- Rofecoxib does not appear to increase the risk of venous thromboembolism: A systematic review of the literature. Thrombosis Research. 134:997-1003. 2014
- The thrombogenicity of C1 esterase inhibitor (human): Review of the evidence. Allergy and Asthma Proceedings. 35:444-453. 2014
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood. 124:2450-2458. 2014
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants. Journal of the American College of Cardiology. 64:1128-1139. 2014
- Portal Vein Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 20:498-506. 2014
- γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo. Journal of Thrombosis and Haemostasis. 12:1110-1115. 2014
- Unusual venous thrombosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:697.3-698. 2014
- Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial. Journal of Critical Care. 29:470.e7-470.e15. 2014
- Venous Thromboembolism in Older Adults: A Community-based Study. American Journal of Medicine. 127:530-537.e3. 2014
- Symptomatic Venous Thromboembolism Uncommon without Thromboprophylaxis After Isolated Lower-Limb Fracture. Journal of Bone and Joint Surgery. American volume. 96:e83-e83. 2014
- The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery. Survey of Anesthesiology. 58:62-63. 2014
- Myocardial Injury after Noncardiac Surgery. Anesthesiology. 120:564-578. 2014
- Warfarin Interactions With Antibiotics in the Ambulatory Care Setting. JAMA Internal Medicine. 174:409-409. 2014
- How I treat target-specific oral anticoagulant–associated bleeding. Blood. 123:1152-1158. 2014
- Practical aspects of new oral anticoagulant use in atrial fibrillation. Polskie Archiwum Medycyny Wewnetrznej. 124:124-135. 2014
- Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:E52-E60. 2014
- Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”. Thrombosis and Haemostasis. 112:841-841. 2014
- Evidence and Clinical Judgment: Vena cava filters. Thrombosis and Haemostasis. 111:618-624. 2014
- Prediction Scores Do Not Correlate with Clinically Adjudicated Categories of Pulmonary Embolism in Critically Ill Patients. Canadian Respiratory Journal. 21:36-42. 2014
- Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit. Critical Care. 18:R82-R82. 2014
- Phase 4 research: what happens when the rubber meets the road?. Hematology. American Society of Hematology. Education Program. 2013:15-18. 2013
- The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Hematology. American Society of Hematology. Education Program. 2013:9-14. 2013
- The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 122:3879-3883. 2013
- Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes. Thrombosis Research. 132:770-775. 2013
- Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Medicine. 39:2135-2143. 2013
- Personalized benefit-harm information influences patient decisions regarding warfarin. Journal of Population Therapeutics and Clinical Pharmacology. 20. 2013
- Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis. Chest. 144:1207-1215. 2013
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*. Critical Care Medicine. 41:2069-2079. 2013
- Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness. Chest. 144:848-858. 2013
- Treatment with novel oral anticoagulants. Current Opinion in Hematology. 20:430-436. 2013
- Nonadherence with INR Monitoring and Anticoagulant Complications. Thrombosis Research. 132:e124-e130. 2013
- Reversal of target-specific oral anticoagulants. Journal of Thrombosis and Thrombolysis. 36:195-202. 2013
- Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Cleveland Clinic Journal of Medicine. 80:443-451. 2013
- The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery. Anesthesia and Analgesia. 117:14-22. 2013
- Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty. ACP journal club. 158:800-800. 2013
- FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:1146-1153. 2013
- Optimal treatment duration of venous thrombosis. Journal of Thrombosis and Haemostasis. 11:151-160. 2013
- Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI. ACP journal club. 158:JC13-JC13. 2013
- Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply. JAMA Internal Medicine. 173:833-833. 2013
- Abstract 10: Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Pharmacokinetic and Pharmacodynamic Study of PRT064445, a Universal Antidote for Factor Xa Inhibitors. Arteriosclerosis, Thrombosis and Vascular Biology. 33. 2013
- Indications, Complications, and Management of Inferior Vena Cava Filters. JAMA Internal Medicine. 173:513-513. 2013
- American College of Chest Physicians Guidelines for Heparin-Induced Thrombocytopenia: Response. Chest. 143:1191-1191. 2013
- Medical prophylaxis: the value of an “opt in” policy. Journal of Thrombosis and Thrombolysis. 35:368-370. 2013
- Proceedings of the 12th national conference on anticoagulant therapy. Journal of Thrombosis and Thrombolysis. 35:303-303. 2013
- Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. Journal of Thrombosis and Haemostasis. 11:474-480. 2013
- The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal. Journal of Thrombosis and Haemostasis. 11:566-567. 2013
- Acute management of bleeding in patients on novel oral anticoagulants. European Heart Journal. 34:489-498. 2013
-
Selective
d -Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. ACP journal club. 158:93-93. 2013 - A guide to GRADE guidelines for the readers of JTH. Journal of Thrombosis and Haemostasis. 11:1603-1608. 2013
- A response to–There’s madness in their methods. Journal of Thrombosis and Haemostasis. 11:785-786. 2013
- Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays. Methods in molecular biology (Clifton, N.J.). 992:387-405. 2013
- Lupus Anticoagulant Testing. Methods in molecular biology (Clifton, N.J.). 992:97-108. 2013
- Non-OO blood type influences the risk of recurrent venous thromboembolism. Thrombosis and Haemostasis. 110:1172-1179. 2013
- Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 11:177-179. 2013
- Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia. Seminars in Hematology. 50:S18-S21. 2013
- 118. Critical Care Medicine. 40:1-328. 2012
- 337. Critical Care Medicine. 40:1-328. 2012
- Blood smear: fulminant pneumococcal bacteremia. Blood. 120:4459-4459. 2012
- Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 120:4160-4167. 2012
- Uncertainties in baseline risk estimates and confidence in treatment effects. The BMJ. 345:e7401-e7401. 2012
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation. Circulation. 126:2381-2391. 2012
- Aspirine versus HBPM en prévention des TVP après PTH : une étude randomisée en double insu (étude Epcat). Revue de Chirurgie Orthopedique et Traumatologique. 98:S355-S355. 2012
- Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding. JAMA Internal Medicine. 172:1484-1484. 2012
- Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection. Survey of Anesthesiology. 56:208-209. 2012
- Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding. Seminars in Vascular Medicine. 38:702-710. 2012
- In Reply. Anesthesiology. 117:921-922. 2012
- Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. Journal of Thrombosis and Haemostasis. 10:2039-2044. 2012
- Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis. Survey of Anesthesiology. 56:244-245. 2012
- Thromboprophylaxis in medical inpatients reduces pulmonary embolism, increases the risk of major haemorrhage and does not reduce total mortality, producing questionable net clinical benefit. BMJ Evidence-Based Medicine. 17:154-155. 2012
- Ustekinumab associated thrombotic thrombocytopenic purpura. Transfusion and Apheresis Science. 47:185-188. 2012
- Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study. Thrombosis Research. 130:381-389. 2012
- Dabigatran-Induced Acute Hepatitis. Clinical and Applied Thrombosis/Hemostasis. 18:549-550. 2012
- Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda. African Health Sciences. 12:268-275. 2012
- Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of Thrombosis and Haemostasis. 10:1830-1840. 2012
- Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement. Thrombosis Research. 130:166-172. 2012
- Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage. Haemophilia. 18:593-597. 2012
- Erratum. American Journal of Hematology. 87:748-748. 2012
- Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil. Journal of Thrombosis and Thrombolysis. 34:143-163. 2012
- MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot–Marie–Tooth disease type 1B. Brain. 135:2032-2047. 2012
- Newer Anticoagulants in Critically Ill Patients. Critical Care Clinics. 28:427-451. 2012
- Reversal of Warfarin. Circulation. 125:2944-2947. 2012
- Bone marrow aspirate collection and preparation – A comparison of three methods. Clinical and Investigative Medicine. 35:114-114. 2012
- Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis. Journal of Thrombosis and Haemostasis. 10:1036-1042. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. American Journal of Hematology. 87:S141-S145. 2012
- Iron Overload in Human Disease. New England Journal of Medicine. 366:1548-1550. 2012
- Amyloidosis and Giant Cell Arteritis/Polymyalgia Rheumatica. Journal of Rheumatology. 39:878-880. 2012
- Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 10:512-520. 2012
- Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records. Journal of Thrombosis and Haemostasis. 10:596-605. 2012
- Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation. Thrombosis Research. 129:526-529. 2012
- Reversing Anticoagulant Therapy. Current Drug Discovery Technologies. 9:143-149. 2012
- How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood. 119:3016-3023. 2012
- Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection. Anesthesiology. 116:613-621. 2012
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- Consequences of suspected heparin-induced thrombocytopenia in the ICU. Critical Care. 16:p423. 2012
- Diagnosis of DVT. Chest. 141:e351S-e418S. 2012
- Evidence-Based Management of Anticoagulant Therapy. Chest. 141:e152S-e184S. 2012
- In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis. Critical Care. 16:P435-P435. 2012
- Oral Anticoagulant Therapy. Chest. 141:e44S-e88S. 2012
- Treatment and Prevention of Heparin-Induced Thrombocytopenia. Chest. 141:e495S-e530S. 2012
- Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis. Journal of the American Medical Association (JAMA). 307:294-303. 2012
- Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 141:e419S-e496S. 2012
- Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141:e185S-e194S. 2012
- Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 141:7S-7S. 2012
- Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 141:48S-52S. 2012
- Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141:53S-70S. 2012
- Neutralization of Heparin Activity. Handbook of Experimental Pharmacology. 207:265-277. 2012
- Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. Blood. 118:6269-6273. 2011
- A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit. Journal of Critical Care. 26:636.e7-636.e13. 2011
- Rajasekhar A, Crowther MA. ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients? Hematology Am Soc Hematol Educ Program. 2009;2009:302-304.. Hematology. American Society of Hematology. Education Program. 2011:561-561. 2011
- Treatment of warfarin-associated coagulopathy with vitamin K. Expert Review of Hematology. 4:657-667. 2011
- 4Ts HIT Scoring in the Medical-Surgical ICU. Blood. 118:4669-4669. 2011
- A Retrospective Review of the Management of Patients with Porphyria Cutanea Tarda At a Tertiary Care Centre. Blood. 118:5290-5290. 2011
- Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study. Blood. 118:1236-1236. 2011
- Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study. Blood. 118:2299-2299. 2011
- Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,. Blood. 118:3332-3332. 2011
- Laboratory HIT Testing in Critically Ill Patients. Blood. 118:198-198. 2011
- Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study. Blood. 118:712-712. 2011
- Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Literature,. Blood. 118:3334-3334. 2011
- The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,. Blood. 118:4207-4207. 2011
- Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism. British Journal of Haematology. 155:511-513. 2011
- Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies. Thrombosis Research. 128:422-430. 2011
- The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy. Clinical and Applied Thrombosis/Hemostasis. 17:E106-E113. 2011
- Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood. 118:4036-4040. 2011
- Introduction: Practical Issues in Hemostasis and Thrombosis. Seminars in Hematology. 48:241-241. 2011
- Management of Bleeding Complications in the Anticoagulated Patient. Seminars in Hematology. 48:285-294. 2011
- Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia. New England Journal of Medicine. 365:734-741. 2011
- A Pilot Study on the Randomization of Inferior Vena Cava Filter Placement for Venous Thromboembolism Prophylaxis in High-Risk Trauma Patients. Journal of Trauma and Acute Care Surgery. 71:323-329. 2011
- Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil. Journal of Thrombosis and Thrombolysis. 32:242-266. 2011
- A further use for the Harvest plot: a novel method for the presentation of data synthesis. Research Synthesis Methods. 2:79-83. 2011
- Predictors of 4-Year Retention Among African American and White Community-Dwelling Participants in the UAB Study of Aging. The Gerontologist. 51:S46-S58. 2011
- Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. Journal of Thrombosis and Haemostasis. 9:1126-1132. 2011
- Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio*. Critical Care Medicine. 39:1507-1513. 2011
- Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP). Health Technology Assessment. 15:23-32. 2011
- Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure. American Society of Nephrology. Clinical Journal. 6:1018-1024. 2011
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 117:4190-4207. 2011
- Dalteparin versus Unfractionated Heparin in Critically Ill Patients. New England Journal of Medicine. 364:1305-1314. 2011
- Update in Hematology and Oncology: Evidence Published in 2010. ACP journal club. 154:487-487. 2011
- Brand Name versus Generic Warfarin: A Systematic Review of the Literature. Pharmacotherapy. 31:386-393. 2011
- PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan. Journal of Critical Care. 26:223.e1-223.e9. 2011
- Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies. Lupus. 20:206-218. 2011
- Management of deep vein thrombosis diagnosed during active labour. Thrombosis Research. 127:170-170. 2011
- Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review. Transfusion Medicine Reviews. 25:61-65. 2011
- Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study. Critical Care. 15:R263-R263. 2011
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. Thrombosis and Haemostasis. 106:429-438. 2011
- The “age” of understanding VKA dose. Blood. 116:5789-5790. 2010
- A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system. BMC Geriatrics. 10:38. 2010
- Being underweight may reduce your ability to mobilise peripheral blood stem cells. Transfusion and Apheresis Science. 43:365-367. 2010
- Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 50:2577-2581. 2010
- Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung. Praxis: a journal of writing and building. 99:1569-1573. 2010
- The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion. Journal of Thrombosis and Haemostasis. 8:2642-2650. 2010
- Comparison of Incidence and Investigation of In-Hospital Pulmonary Embolism In Patients Receiving Dalteparin Prophylaxis Following Elective Knee Replacement at Two Hospitals. Blood. 116:4388-4388. 2010
- Prothrombin Complex Concentrate (Octaplex®) In Patients Requiring Immediate Reversal of Vitamin K Antagonist Anticoagulation.. Blood. 116:1115-1115. 2010
- SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.. Blood. 116:1113-1113. 2010
- Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Hematology Journal. 95:1952-1959. 2010
- Safety of thrombolysis in cerebral venous thrombosis A systematic review of the literature. Thrombosis and Haemostasis. 104:1055-1062. 2010
- Systematic review and meta-analysis methodology. Blood. 116:3140-3146. 2010
- Antiphospholipid syndrome. The Lancet. 376:1498-1509. 2010
- Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss. Obstetrics and Gynecology. 116:997-998. 2010
- New Anticoagulants for the Prevention of Thromboembolism. Current Pharmaceutical Design. 16:3472-3474. 2010
- Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism. Journal of Thrombosis and Haemostasis. 8:1926-1932. 2010
- Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE. Thrombosis Research. 126:222-226. 2010
- Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations. Hematology/Oncology Clinics of North America. 24:669-676. 2010
- Preface. Hematology/Oncology Clinics of North America. 24:xiii-xiv. 2010
- Surveillance duplex scanning to prevent venous thromboembolism: does it make a difference in rehabilitation unit patients?. Journal of Thrombosis and Haemostasis. 8:1872-1874. 2010
- Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 50:1722-1730. 2010
- Use of the Delphi method to establish guidelines for treatment of thrombosis. Thrombosis Research. 126:79-80. 2010
- Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. Journal of Thrombosis and Haemostasis. 8:1266-1270. 2010
- The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. Journal of Critical Care. 25:287-293. 2010
- The Influence of Perioperative Coagulation Status on Postoperative Blood Loss in Complex Cardiac Surgery. Anesthesia and Analgesia. 110:1533-1540. 2010
- Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents. Circulation. 121:2067-2070. 2010
- D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. Journal of Thrombosis and Haemostasis. 8:1004-1011. 2010
- Practical management of coagulopathy associated with warfarin. The BMJ. 340:c1813-c1813. 2010
- Practical management of coagulopathy associated with warfarin.. The BMJ. 340:c1813. 2010
- Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users. Journal of Thrombosis and Haemostasis. 8:744-749. 2010
- Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery. ACP journal club. 152:JC3-JC3. 2010
- Antiphospholipid antibodies in critical illness. Critical Care Medicine. 38:S51-S56. 2010
- Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome. Current Rheumatology Reports. 12:64-69. 2010
- Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients. Critical Care Medicine. 38:S76-S82. 2010
- The new oral anticoagulants. Blood. 115:15-20. 2010
- Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys. Thrombosis and Haemostasis. 104:837-844. 2010
- Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Thrombosis and Haemostasis. 104:118-121. 2010
- Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Thrombosis and Haemostasis. 104:498-503. 2010
- Safety of thrombolysis in cerebral venous thrombosis. Thrombosis and Haemostasis. 104:1055-1062. 2010
- The vexing problem of guidelines and conflict of interest: a potential solution. ACP journal club. 152:738-741. 2010
- The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemporary Clinical Trials. 31:131-133. 2010
- Venous thromboembolism, age and hospitalisation: A potentially deadly combination. Thrombosis and Haemostasis. 104:655-656. 2010
- Prevalence and morphological types of anaemia and hookworm infestation in the medical emergency ward, Mulago Hospital, Uganda.. Southern African Journal of Critical Care. 99:881-886. 2009
- Inaccurate Doses of Rh Immune Globulin After Rh-Incompatible Fetomaternal Hemorrhage—Survey of Laboratory Practice. Archives of Pathology and Laboratory Medicine. 133:1910-1911. 2009
- Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. Journal of Thrombosis and Haemostasis. 7:1982-1989. 2009
- Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?. Obstetrical and Gynecological Survey. 64:781-783. 2009
- A Cohort Study of Warfarin Administered to Achieve An INR of 2.0 to 3.0 for the Prevention of Recurrent Venous Thrombosis in Patients with An Antiphospholipid Antibody.. Blood. 114:3123-3123. 2009
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 114:1412-1412. 2009
- Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review.. Blood. 114:4447-4447. 2009
- Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the “Men Continue and HERDOO2” Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).. Blood. 114:451-451. 2009
- Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically Ill Patients.. Blood. 114:3995-3995. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.. Blood. 114:2418-2418. 2009
- Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors.. Blood. 114:2978-2978. 2009
- The Kids-DOTT Trial: Novel Aspects of the ‘Parallel Cohort RCT‘ Design and Its Application to the Investigation of Duration of Anticoagulant Therapy for Pediatric Venous Thromboembolism.. Blood. 114:4169-4169. 2009
- Correction: Predicting Deep Venous Thrombosis in Pregnancy. ACP journal club. 151:516-516. 2009
- Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplantation. 44:413-425. 2009
- Vitamin K to Correct Overanticoagulation. ACP journal club. 151:435-435. 2009
- A logical approach to surgical thromboprophylaxis. Current Opinion in Hematology. 16:397-401. 2009
- Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Current Opinion in Pulmonary Medicine. 15:455-462. 2009
- ERRATA. Transfusion. 49:2012-2012. 2009
- Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention. American Journal of Hematology. 84:579-583. 2009
- Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. American Journal of Hematology. 84:584-588. 2009
- The diagnosis of myocardial infarction in critically ill patients: An agreement study. Journal of Critical Care. 24:447-452. 2009
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006). Transfusion. 49:2012-2012. 2009
- 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Polskie Archiwum Medycyny Wewnetrznej. 119:541-549. 2009
- Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage. Expert Review of Hematology. 2:357-360. 2009
- Symposium 4: Hot topics in parenteral nutrition A review of the use of glutamine supplementation in the nutritional support of patients undergoing bone-marrow transplantation and traditional cancer therapy. Proceedings of the Nutrition Society. 68:269-273. 2009
- Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 114:952-956. 2009
- Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?. ACP journal club. 151:85-85. 2009
- A case of apples and pears?. Blood. 113:6259-6260. 2009
- Definition of major bleeding used by US anticoagulation clinics. Thrombosis Research. 124:239-240. 2009
- Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis. Journal of Critical Care. 24:168-175. 2009
- In Reply to ‘Erythropoietin and Cancer: An Old Risk’. American Journal of Kidney Diseases. 53:1102-1103. 2009
- Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review. Journal of Critical Care. 24:197-205. 2009
- Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Hematology Journal. 94:850-856. 2009
- Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 49:1171-1177. 2009
- JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 113:5617-5623. 2009
- Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome. Circulation. 119:2420-2422. 2009
- Validation of a diagnostic approach to exclude recurrent venous thromboembolism. Journal of Thrombosis and Haemostasis. 7:752-759. 2009
- Severe Hemolytic Anemia Post–Renal Transplantation Produced by Donor Anti-D Passenger Lymphocytes: Case Report and Literature Review. Transfusion Medicine Reviews. 23:155-159. 2009
- Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. ACP journal club. 150:293-293. 2009
- Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials. Thrombosis Research. 123:687-696. 2009
- Acute Kidney Injury After Cardiac Surgery. Circulation. 119:495-502. 2009
- Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.. Journal of Rheumatology. 36:279-287. 2009
- A systematic review of nutritional support in haematopoietic stem cell transplantation. Proceedings of the Nutrition Society. 68:e52. 2009
- ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients?. Hematology. American Society of Hematology. Education Program. 2009:302-304. 2009
- Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Blood Coagulation and Fibrinolysis. 20:47-51. 2009
- Introduction to surrogates and evidence-based mini-reviews. Hematology. American Society of Hematology. Education Program. 2009:15-16. 2009
- Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists. Thrombosis and Haemostasis. 102:501-504. 2009
- Venous thromboembolism and bleeding in a community setting. Thrombosis and Haemostasis. 101:878-885. 2009
- Erythropoietin-Stimulating Agents: Ongoing Concerns With Safety. American Journal of Kidney Diseases. 52:1039-1041. 2008
- Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 112:4432-4436. 2008
- Preventing and managing bleeding complications in anticoagulated patients: A case based approach. Thrombosis Research. 123:S42-S45. 2008
- Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review. BMC Geriatrics. 8:13. 2008
- Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients. Blood. 112:170-170. 2008
- Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study. Blood. 112:3027-3027. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.. Blood. 112:3413-3413. 2008
- The Impact of Deep Vein Thrombosis on Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis. Blood. 112:3023-3023. 2008
- Human-Derived D-Dimer for External Quality Assessment. American Journal of Clinical Pathology. 130:805-810. 2008
- Thromboprophylaxis in medical–surgical critically ill patients. Current Opinion in Critical Care. 14:520-523. 2008
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. JAMA Internal Medicine. 168:1805-1805. 2008
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 179:417-426. 2008
- Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation. Journal of Clinical Pharmacology. 48:909-918. 2008
- Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum. Annals of Pharmacotherapy. 42:979-988. 2008
- Preventing Venous Thromboembolism in Critically Ill Patients. Seminars in Vascular Medicine. 34:469-474. 2008
- Pharmacology and Management of the Vitamin K Antagonists. Chest. 133:160S-198S. 2008
- Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood. 111:4871-4879. 2008
- Thrombotic thrombocytopenic purpura: 2008 Update. Cleveland Clinic Journal of Medicine. 75:369-375. 2008
- The Reply. American Journal of Medicine. 121:e7-e7. 2008
- The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. European Heart Journal. 29:1057-1071. 2008
- Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 6:405-414. 2008
- Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. Journal of Thoracic and Cardiovascular Surgery. 135:705-706. 2008
- A Multicenter Trial of the Effectiveness of ζ-Globin Enzyme-Linked Immunosorbent Assay and Hemoglobin H Inclusion Body Screening for the Detection of α0-Thalassemia Trait. American Journal of Clinical Pathology. 129:309-315. 2008
- Re-examining aggressive anticoagulant therapy: the case of acute coronary syndromes. Nature Reviews Cardiology. 5:72-73. 2008
- A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy. Obstetrical and Gynecological Survey. 63:1-2. 2008
- Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery. ACP journal club. 148:21-21. 2008
- Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings. Critical Care. 12:R36-R36. 2008
- Evidence-Based Guidelines—An Introduction. Hematology. American Society of Hematology. Education Program. 2008:26-30. 2008
- Geographic variation in the reversal of vitamin K antagonist-associated coagulopathy. Critical Care. 12:P220-P220. 2008
- Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Thrombosis Research. 123:24-34. 2008
- Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists. Hematology. American Society of Hematology. Education Program. 2008:266-270. 2008
- Reply. Annals of Thoracic Surgery. 85:361-361. 2008
- Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice. Thrombosis Research. 122:864-866. 2008
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors. Critical Care. 12:R32-R32. 2008
- What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?. Hematology. American Society of Hematology. Education Program. 2008:36-38. 2008
- A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study.. Blood. 110:698-698. 2007
- Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentary. Polskie Archiwum Medycyny Wewnetrznej. 117:494-496. 2007
- How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood. 110:3122-3127. 2007
- Anticoagulant Prophylaxis for Hospitalized Medical Patients. ACP journal club. 147:524-524. 2007
- In response. Annals of Internal Medicine. 147:524. 2007
- Inferior Vena Cava Filters in the Management of Venous Thromboembolism. American Journal of Medicine. 120:S13-S17. 2007
- The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists. Journal of Thrombosis and Haemostasis. 5:2157-2159. 2007
- Targeting Anemia with Erythropoietin during Critical Illness. New England Journal of Medicine. 357:1037-1039. 2007
- Antiphospholipid antibiodies: a critical review of the literature. Current Opinion in Hematology. 14:494-499. 2007
- Low molecular weight heparin and bleeding in patients with chronic renal failure. Current Opinion in Pulmonary Medicine. 13:409-413. 2007
- In response. Annals of Internal Medicine. 147:281-282. 2007
- Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. ACP journal club. 147:281-281. 2007
-
A Red Blood Cell Agglutination
d -Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy. ACP journal club. 147:165-165. 2007 - Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. Journal of Thrombosis and Thrombolysis. 24:93-97. 2007
- CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL. Journal of Thrombosis and Haemostasis. 5:o-t-051-o-t-051. 2007
- DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY. Journal of Thrombosis and Haemostasis. 5:p-s-680-p-s-680. 2007
- Fresh frozen plasma transfusion in critically ill patients*. Critical Care Medicine. 35:1655-1659. 2007
- The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference. Canadian Journal of Anaesthesia. 54:573-582. 2007
- Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K. Annals of Thoracic Surgery. 84:103-108. 2007
- Should you add aspirin to your heart patient's warfarin regimen?. Journal of Family Practice. 56:430. 2007
- Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.. Journal of Rheumatology. 34:992-996. 2007
- Paper-based dosing algorithms for maintenance of warfarin anticoagulation. Journal of Thrombosis and Thrombolysis. 23:195-198. 2007
- An abnormal D-dimer test result indicated that anticoagulant therapy should be continued. BMJ Evidence-Based Medicine. 12:45-45. 2007
-
An abnormal
D -dimer test result indicated that anticoagulation should be continued. ACP journal club. 146:29-29. 2007 - Fondaparinux – evolution or revolution in anticoagulant care?. Polskie Archiwum Medycyny Wewnetrznej. 117:65-67. 2007
- Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients. ACP journal club. 146:278-278. 2007
- Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario. American Journal of Clinical Pathology. 127:192-196. 2007
- Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease. JAMA Internal Medicine. 167:117-117. 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. ACP journal club. 146:25-25. 2007
- A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.. Journal of Population Therapeutics and Clinical Pharmacology. 14:e215-e226. 2007
- A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.. Journal of Population Therapeutics and Clinical Pharmacology. 14:e215-e226. 2007
- Prevention and treatment of venous thromboembolism in the elderly patient.. Clinical interventions in aging. 2:237-246. 2007
- Trials and Tribulations of Systematic Reviews and Meta-Analyses. Hematology. American Society of Hematology. Education Program. 2007:493-497. 2007
- When is HIT Really HIT?. Annals of Thoracic Surgery. 83:21-23. 2007
- Elevated Cardiac Troponin Measurements in Critically Ill Patients. JAMA Internal Medicine. 166:2446-2446. 2006
- ELEVATED TROPONIN MEASUREMENTS IN THE CRITICALLY ILL.. Critical Care Medicine. 34:A58-A58. 2006
- New anticoagulants and the management of their bleeding complications. Transfusion Alternatives in Transfusion Medicine. 8:12-19. 2006
- Safety and Efficacy of Anti-Fibrinolytics in Orthopedic Surgery: A Meta-Analysis of Randomized Trials.. Blood. 108:628-628. 2006
- The Management of Anticoagulated Patients Requiring Dental Extraction: A Cross-Sectional Survey of Oral Surgeons and Hematologists.. Blood. 108:629-629. 2006
- Unexpected Harmful Side Effects Triggered by Immune Modulation.. Blood. 108:4008-4008. 2006
- Use of Therapeutic Dose Low Molecular Weight Heparin in Patients with Renal Insufficiency: Analysis of Anti-Xa Levels and Creatinine Clearance.. Blood. 108:884-884. 2006
- Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.. Journal of Rheumatology. 33:2222-2226. 2006
- Acquired Thrombophilia during Pregnancy. Obstetrics and Gynecology Clinics of North America. 33:375-388. 2006
- The metabolic syndrome and the risk of venous thrombosis: a case–control study. Journal of Thrombosis and Haemostasis. 4:1914-1918. 2006
- Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms. Journal of Thrombosis and Haemostasis. 4:1853-1863. 2006
- Natural history of cerebral vein thrombosis: a systematic review. Blood. 108:1129-1134. 2006
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion. 46:1286-1291. 2006
- What makes a good ICU?. Australian Critical Care. 19:85-85. 2006
- Treatment of Antiphospholipid Antibody Syndrome—Reply. Journal of the American Medical Association (JAMA). 296:42-42. 2006
- Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial. Annals of Pharmacotherapy. 40:1241-1247. 2006
- Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Haematologica. 91:976-979. 2006
- Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.. Hematology Journal. 91:976-979. 2006
-
An Evaluation of
d -Dimer in the Diagnosis of Pulmonary Embolism. ACP journal club. 144:812-812. 2006 - Management of antiphospholipid antibody syndrome.. Journal of Family Practice. 55:479. 2006
- Practice patterns for deep vein thrombosis prophylaxis in minimal-access surgery.. Canadian Journal of Surgery. 49:197-202. 2006
- Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency. ACP journal club. 144:673-673. 2006
- Elevated Cardiac Troponin Levels in Critically Ill Patients: Prevalence, Incidence, and Outcomes. American Journal of Critical Care. 15:280-288. 2006
- Reliability of electrocardiogram interpretation in critically ill patients. Critical Care Medicine. 34:1338-1343. 2006
- Reliability of electrocardiogram interpretation in critically ill patients*. Critical Care Medicine. 34:1338-1343. 2006
- Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 107:2766-2773. 2006
- Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review. American Journal of Geriatric Pharmacotherapy. 4:75-77. 2006
- Management of Antiphospholipid Antibody Syndrome. Journal of the American Medical Association (JAMA). 295:1050-1050. 2006
- Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study*. Critical Care Medicine. 34:694-699. 2006
- The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy. Journal of the American College of Cardiology. 47:804-808. 2006
- Bleeding in patients with renal insufficiency: A practical guide to clinical management. Thrombosis Research. 118:423-428. 2006
- Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients. PharmacoEconomics (Auckland). 24:593-607. 2006
- Effect of chronic kidney disease on red blood cell rheology.. Clinical Hemorheology and Microcirculation. 34:411-420. 2006
- Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy. Thrombosis and Haemostasis. 95:1038-1039. 2006
- Measuring the anticoagulant effect of low molecular weight heparins in the critically ill.. Critical Care. 10:150-150. 2006
- Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Canadian Journal of Cardiology. 22:47-53. 2006
- The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol. Thrombosis and Haemostasis. 96:387-389. 2006
- Uremic bleeding: Pathophysiology and clinical risk factors. Thrombosis Research. 118:417-422. 2006
- Thromboembolic complications of malignancy: Part 1: Risk. Commentary. Oncology. 19. 2005
- Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency. Journal of Critical Care. 20:324-329. 2005
- Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. Journal of Critical Care. 20:357-363. 2005
- Deep venous thrombosis: clinically silent in the intensive care unit. Journal of Critical Care. 20:334-340. 2005
- On the need for a workshop on venous thromboembolism in critical care. Journal of Critical Care. 20:306-308. 2005
- Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. Journal of Critical Care. 20:309-313. 2005
- Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. Journal of Critical Care. 20:364-372. 2005
- Research agenda: venous thromboembolism in medical-surgical critically ill patients. Journal of Critical Care. 20:330-333. 2005
- The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients. Journal of Critical Care. 20:314-319. 2005
- The incidence and impact of lupus anticoagulants among patients in the intensive care unit.. Saudi Medical Journal. 26:1994-1995. 2005
- Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Journal of Critical Care. 20:348-353. 2005
- Thromboprophylaxis in medical-surgical intensive care unit patients. Journal of Critical Care. 20:320-323. 2005
- A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.. Blood. 106:583-583. 2005
- Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.. Blood. 106:906-906. 2005
- Low Molecular Weight Heparin and Bleeding in Patients with Severe Renal Failure: A Meta-Analysis.. Blood. 106:907-907. 2005
- Rituximab for the Treatment of Adults with ITP: A Systematic Review.. Blood. 106:1241-1241. 2005
- Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.. Blood. 106:547-547. 2005
- Anticoagulation therapy in the antiphospholipid syndrome: recent advances. Current Opinion in Pulmonary Medicine. 11:368-372. 2005
- Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy. Journal of Thrombosis and Haemostasis. 3:2121-2123. 2005
- Proficiency Testing of Reticulocyte Counting in Ontario. Laboratory Hematology. 11:185-189. 2005
- Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?. Circulation. 112:e85-e90. 2005
- Perioperative Anticoagulation for Patients With Mechanical Heart Valves: A Survey of Current Practice. ACC Current Journal Review. 14:5-6. 2005
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials. Annals of Pharmacotherapy. 39:1188-1193. 2005
- Bleeding in Cardiac Surgery: Its Prevention and Treatment—an Evidence-Based Review. Critical Care Clinics. 21:589-610. 2005
- Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. Critical Care Medicine. 33:1565-1571. 2005
- Thrombo-embolic complications of malignancy - Part 2: Management - The Linenberger/Wittkowsky article reviewed. Oncology. 19:1087-1088. 2005
- Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease. British Journal of Haematology. 129:803-810. 2005
- Warfarin Maintenance Dosing Patterns in Clinical Practice. Chest. 127:2049-2056. 2005
- Systematic Overview of Warfarin and Its Drug and Food Interactions. JAMA Internal Medicine. 165:1095-1095. 2005
- Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study. Journal of Thrombosis and Haemostasis. 3:943-948. 2005
-
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis:
d -Dimer Testing Compared with Repeated Ultrasonography. ACP journal club. 142:490-490. 2005 - Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 3:718-723. 2005
- Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.. Cleveland Clinic Journal of Medicine. 72:245-249. 2005
- Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary? (vol 3, pg 216, 2004). Journal of Thrombosis and Haemostasis. 3:622-622. 2005
- Tailoring warfarin induction doses to reflect individual and disease-specific factors. American Journal of Medicine. 118:143-144. 2005
- Video laparoscopic surgery: is out‐of‐hospital thromboprophylaxis necessary?. Journal of Thrombosis and Haemostasis. 3:216-220. 2005
- Acute myocardial infarction: incidence and outcomes in an intensive care unit. Critical Care. 9:P315-P315. 2005
- Anticoagulants and Gastrointestinal Bleeding. Canadian Journal of Gastroenterology and Hepatology. 19:535-537. 2005
- Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.. Journal of Population Therapeutics and Clinical Pharmacology. 12:e229-e239. 2005
- Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thrombosis and Haemostasis. 94:528-531. 2005
- Elevated troponin and myocardial infarction in the intensive care unit: a prospective study.. Critical Care. 9:R636-R636. 2005
- Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis. Thrombosis Research. 115:3-8. 2005
- Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Medicine. 31:48-55. 2005
- Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.. Hematology Journal. 90:137-139. 2005
- Pathogenesis of Atherosclerosis. Hematology. American Society of Hematology. Education Program. 2005:436-441. 2005
- Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians. Yonsei Medical Journal. 46:66-66. 2005
- The reliability of electrocardiogram interpretation in critically ill patients. Critical Care. 9:P320-P320. 2005
- Troponin incidence, prevalence and prognosis among critically ill patients. Critical Care. 9:P311-P311. 2005
- Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood. 104:3958-3964. 2004
- Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery. Blood Coagulation and Fibrinolysis. 15:623-628. 2004
- Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice. Journal of Thrombosis and Thrombolysis. 18:199-203. 2004
- Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure. Journal of the American Society of Nephrology. 15:3192-3206. 2004
- Safety and efficacy of low molecular weight heparins for hem dialysis in patients with end-stage renal failure: A meta-analysis of randomized trials. Journal of the American Society of Nephrology. 15:3192-3206. 2004
- A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.. Blood. 104:492-492. 2004
- Anti-Xa Levels in Critically Ill Patients Receiving Dalteparin for Thromboprophylaxis.. Blood. 104:4075-4075. 2004
- Comparison of Compression Ultrasound vs Ascending Contrast Venography for Proximal DVT in Medical-Surgical ICU Patients.. Blood. 104:2603-2603. 2004
- Safety and Efficacy of Venous Thromboembolism Prophylaxis with Low Molecular Weight Heparin in Hospitalised Patients with Acute Medical Illness and Renal Failure.. Blood. 104:4078-4078. 2004
- The Risk of Hemorrhage and the Frequency of Vitamin K Use in Asymptomatic Patients with Warfarin-Associated Coagulopathy.. Blood. 104:527-527. 2004
- Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis. ACP journal club. 141:74-74. 2004
- New anticoagulants: an update.. Clinical Advances in Hematology and Oncology. 2:743-749. 2004
- Warfarin cessation prior to cardiopulmonary bypass. Journal of Surgical Research. 121:284-284. 2004
- Acute reversal of anticoagulant-induced bleeding complications.. Clinical Advances in Hematology and Oncology. 2:578-582. 2004
- Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126:174S-178S. 2004
- Antiphospholipid antibody syndrome: further evidence to guide clinical practice?. Journal of Rheumatology. 31:1474-1475. 2004
- Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology. Blood. 103:4383-4388. 2004
- Ximelagatran: the first oral direct thrombin inhibitor. Expert Opinion on Investigational Drugs. 13:403-413. 2004
- Ximelagatran: the first oral direct thrombin inhibitor.. Expert Opinion on Investigational Drugs. 13:403-413. 2004
- Randomized Trial of Warfarin Nomograms. ACP journal club. 140:488-488. 2004
- Randomized Trial of Warfarin Nomograms. Annals of Internal Medicine. 140:490-490. 2004
- Randomized trial of warfarin nomograms.. ACP journal club. 140:490-491. 2004
- Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:821-824. 2004
- Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism. Obstetrical and Gynecological Survey. 59:78-80. 2004
- Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists.. Critical Care. 8:R145-R145. 2004
- Evidence-based treatment of the antiphospholipid syndrome. Thrombosis Research. 114:75-81. 2004
- Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Thrombosis Research. 113:205-209. 2004
- Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thrombosis Research. 114:161-165. 2004
- Thrombocytopenia in medical–surgical ICU patients. Critical Care. 8:P125-P125. 2004
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. New England Journal of Medicine. 349:2577-2577. 2003
- Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome. New England Journal of Medicine. 349:2568-2570. 2003
- Warfarin prophylaxis in the antiphospholipid antibody syndrome - Reply. New England Journal of Medicine. 349:2569-2570. 2003
- Lipoprotein(a): another risk factor for venous thrombosis?. American Journal of Medicine. 115:667-668. 2003
- A 44-year-old woman with dry cough and solitary nodule.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 169:696-697. 2003
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. New England Journal of Medicine. 349:1133-1138. 2003
- Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism. New England Journal of Medicine. 349:631-639. 2003
- Unraveling Severe Sepsis. Journal of the American Medical Association (JAMA). 290:256-256. 2003
-
A Diagnostic Strategy Involving a Quantitative Latex
d -Dimer Assay Reliably Excludes Deep Venous Thrombosis. ACP journal club. 138:787-787. 2003 - Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply. Archives of Internal Medicine. 163:981-981. 2003
- Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply. JAMA Internal Medicine. 163:981-981. 2003
- Oral Vitamin K for Warfarin-Associated Coagulopathy. ACP journal club. 138:611-611. 2003
- Oral vitamin K for warfarin-associated coagulopathy.. ACP journal club. 138:610-611. 2003
- Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. ACP journal club. 138:128-128. 2003
- Deep venous thrombosis in medical–surgical ICU patients: prevalence, incidence and risk factors. Critical Care. 7:P111-P111. 2003
- Fetal-Maternal Hemorrhage Detection in Ontario. American Journal of Clinical Pathology. 119:72-77. 2003
- Fetal-maternal hemorrhage detection in Ontario. American Journal of Clinical Pathology. 119:72-77. 2003
- New Anticoagulants. American Journal of Cardiovascular Drugs. 3:201-209. 2003
- Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms. Seminars in Vascular Medicine. 03:255-260. 2003
- Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin k in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. ACC Current Journal Review. 12:15-15. 2003
- Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin. Critical Care. 7:P112-P112. 2003
- Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?. JAMA Internal Medicine. 162:2605-2605. 2002
- Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis. Journal of the American Society of Nephrology. 13:2331-2337. 2002
- Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy. ACP journal club. 137:251-251. 2002
- Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement. JAMA Internal Medicine. 162:1465-1465. 2002
- Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.. Thrombosis and Haemostasis. 88:48-51. 2002
- Direct thrombin inhibitors. Thrombosis Research. 106:V275-V284. 2002
- Selecting patients for home treatment of deep vein thrombosis: the problem of cancer.. Hematology Journal. 87:286-291. 2002
- Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism. JAMA Internal Medicine. 162:79-79. 2002
- Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery. Thrombosis and Haemostasis. 88:37-40. 2002
- Identifying patients at increased risk for recurrent venous thromboembolism: Clinical, biochemical, and radiologic risk factors. Cardiovascular Reviews and Reports. 23:280-285+291. 2002
- Low Dose Oral Vitamin K to Reverse Acenocoumarol-induced Coagulopathy: A Randomized Controlled Trial. Thrombosis and Haemostasis. 88:48-51. 2002
- Mechanisms responsible for the failure of protamine to inactivate low‐molecular‐weight heparin. British Journal of Haematology. 116:178-186. 2002
- Reversing anticoagulants both old and new.. Canadian Journal of Anaesthesia. 49:S11-S25. 2002
- Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. Blood Coagulation and Fibrinolysis. 13:49-52. 2002
- Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study. Journal of Critical Care. 16:161-166. 2001
- Treatment of Warfarin-Associated Coagulopathy. Chest. 120:1972-1976. 2001
- Continuing Challenges of Sepsis Research. Journal of the American Medical Association (JAMA). 286:1894-1894. 2001
- Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. Journal of Leukocyte Biology. 70:478-490. 2001
-
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and
d -dimer Testing. ACP journal club. 135:108-108. 2001 - Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/. American Journal of Medicine. 110:515-519. 2001
- Vitamin K in anticoagulation therapy. The Lancet. 357:637-637. 2001
- Vitamin K in anticoagulation therapy. The Lancet. 357:638-638. 2001
- Anticoagulation Therapy. Hematology. American Society of Hematology. Education Program. 2001:339-357. 2001
- Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study. Thrombosis and Haemostasis. 85:390-394. 2001
- Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.. Journal of Thrombosis and Thrombolysis. 11:127-136. 2001
- Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy. JAMA Internal Medicine. 160:3431-3431. 2000
- A Reliable Screening Test to Identify Adult Carriers of the (--SEA) alpha0-Thalassemia Deletion. American Journal of Clinical Pathology. 114:927-931. 2000
- Effectiveness of reconstituted and then frozen tpa for dysfunctional percutaneous dialysis catheters. Blood. 96. 2000
- Use of vitamin k to reverse warfarin-induced excessive anticoagulation: a survey of current practice habits. Blood. 96. 2000
- Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients. Journal of Critical Care. 15:127-132. 2000
- Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. The Lancet. 356:1551-1553. 2000
- Sibrafiban was not more efficacious than aspirin in preventing death and cardiovascular events in patients with acute coronary syndromes. Evidence-based Cardiovascular Medicine. 4:49-49. 2000
- Stability and sterility of recombinant tissue plasminogen activator at −30°C. The Lancet. 355:2221-2221. 2000
- Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis. Thrombosis Research. 97:395-403. 2000
- Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.. Canadian Journal of Cardiology. 16:326-330. 2000
- Erratum: Sensitivity and specificity of a rapid whole-blood assay for D- dimer in the diagnosis of pulmonary embolism (Annals of Internal Medicine (1998) 129 (1006-1011)). Annals of Internal Medicine. 132:247. 2000
- Management of Patients with Hereditary Hypercoagulable Disorders. Annual Review of Medicine. 51:169-185. 2000
- Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism (vol 129, pg 1006, 1998). Annals of Internal Medicine. 132:247-247. 2000
- Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery. Chest. 116:1240-1246. 1999
- Comparing 5-mg and 10-mg warfarin loading doses: Are the groups similar? Reply. Archives of Internal Medicine. 159:1625-1625. 1999
- ETIOLOGY. Evidence-based Cardiovascular Medicine. 3:34-35. 1999
- The A1/A2 polymorphism of glycoprotein IIIa was not a risk factor for adverse events complicating coronary interventionsand the homozygous 807T/873A polymorphisms of the glycoprotein Ia/IIa collagen receptor gene was associated with acute MI. Evidence-Based Healthcare. 3:34-35. 1999
- What is the best warfarin loading dose... 5 mg or 10 mg?. Journal of Respiratory Diseases. 20:319. 1999
- A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses. JAMA Internal Medicine. 159:46-46. 1999
- The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 82:1028-1032. 1999
- Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism. ACP journal club. 129:1006-1006. 1998
- Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin. JAMA Internal Medicine. 158:2001-2001. 1998
- Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery. ACP journal club. 128:270-270. 1998
- Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin. Thrombosis and Haemostasis. 79:1116-1118. 1998
- Reply: Warfarin: Less May Be Better. ACP journal club. 127:333-333. 1997
- A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. JAMA Internal Medicine. 157:1522-1530. 1997
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. JAMA Internal Medicine. 157:1077-1081. 1997
- Immune Thrombocytopenic Purpura. Journal of Clinical Rheumatology. 3:95-101. 1997
- Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results. Seminars in Vascular Medicine. 23:77-81. 1997
- Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy. ACP journal club. 126:133-133. 1997
- Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results. Thrombosis and Haemostasis. 78:689-692. 1997
- Low molecular weight heparin and asa therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL). American Journal of Obstetrics and Gynecology. 176:S125-S125. 1997
- Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. ACP journal club. 125:294-294. 1996
- The Evaluation of Various Mathematical RBC Indices and Their Efficacy in Discriminating Between Thalassemic and Non-Thalassemic Microcytosis. American Journal of Clinical Pathology. 106:201-205. 1996
- Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Reviews. 10:8-16. 1996
- Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 76:689-691. 1996
- Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy. American Journal of Hematology. 48:132-133. 1995
- Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines. International Journal of Laboratory Hematology. 16:261-272. 1994
- Menstrual Toxic Shock Syndrome Complicated by Persistent Bacteremia: Case Report and Review. Clinical Infectious Diseases. 16:288-289. 1993
- Dideoxyinosine-associated nephrotoxicity. AIDS. 7:131-131. 1993
- GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR FOR THE THERAPY OF CYTOMEGALOVIRUS AND GANCICLOVIR-INDUCED LEUKOPENIA IN A RENAL TRANSPLANT RECIPIENT. Transplantation. 53:930-931. 1992
- Vascular collagen fibril morphology in type IV ehlers-Danlos syndrome. Connective Tissue Research. 25:209-217. 1991
- Coagulation Conundrum. Canadian Journal of General Internal Medicine. 17:34-37.
- Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP). Health Technology Assessment. 15:23-32.
- First Case of COVID-19 N501Y Variant of Concern Infection in a Patient with Chronic HIV Infection. Canadian Journal of General Internal Medicine. 16.
- P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. HemaSphere. 7:e1167638-e1167638.
- P1652: SAFETY OF DOACS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. HemaSphere. 7:e974141e-e974141e.
- P1665: USE OF DOACS IN THE MANAGEMENT OF UPPER EXTREMITY DEEP VENOUS THROMBOSIS; A SYSTEMATIC REVIEW. HemaSphere. 7:e2856211-e2856211.
- P1667: ATTRIBUTES OF RANDOMIZED CONTROLLED TRIALS AND THEIR ASSOCIATIONS WITH FUNDING SOURCE IN VENOUS THROMBOEMBOLISM PROPHYLAXIS FOR PATIENTS WITH CANCER: A BIBLIOGRAPHICAL ANALYSIS. HemaSphere. 7:e8567529-e8567529.
- P1669: DIRECT ORAL ANTICOAGULANTS VS LOW MOLECULAR WEIGHT HEPARIN IN THE MANAGEMENT OF PATIENTS WITH PRIMARY OR METASTATIC BRAIN TUMOURS: A SYSTEMATIC REVIEW AND META-ANALYSIS. HemaSphere. 7:e200448c-e200448c.
- PB2045: USE OF ANAKINRA IN THE TREATMENT OF ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A SYSTEMATIC REVIEW. HemaSphere. 7:e0223224-e0223224.
- Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEXA-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor. EMJ Cardiology. 6:47-51.
- Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal. Health Technology Assessment. 13:63-68.
- Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. Journal of Thrombosis and Haemostasis. no-no.
-
preprints